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Abstract  
Plasmodium falciparum, the deadliest strain of human malaria, affected 200 million people and 
resulted in several hundred thousand deaths in 2017 (World Health Organization, 2018). A better 
understanding of the mechanisms of P. falciparum gene regulation can open novel avenues for the 
development of much needed new drugs.  A key step in eukaryotic gene regulation is the process of 
transcription, which is largely uncharacterized in Plasmodium. Bioinformatic analysis identified 
putatuve P. falciparum orthologues of RNA polymerase II general transcription factors (Bing, 2014; 
Milton, 2017), including a TATA box-binding-like protein, PfTLP. Bioinformatic analysis suggested that 
PfTLP is a TRF2-type TBP-like protein. However, PfTLP differs in several aspects from previously 
characterized TRF2-type proteins. These differences are thought to be Plasmodium specific 
adaptations to the parasite’s intricate life cycle and AT-rich genome. This study investigates two 
Plasmodium-specific features of PfTLP.  Firstly, DNA binding by eukaryotic TATA-box binding protein 
(TBP) is mediated by four evolutionary conserved phenylalanine residues, two of which intercalate 
into the DNA. These residues are absent in previously characterized TRF2-type TLPs, and consistent 
with this, these proteins lack detectable DNA binding activity (Duttke et al., 2014). In contrast, PfTLP, 
a TRF2-type TLP, has DNA binding activity, and all four of the DNA binding phenylalanine residues are 
conserved (Bing, 2014; Milton, 2017). The importance of evolutionary conserved intercalating 
phenylalanine residues F60 and F283 was investigated by generating mutant PfTLP proteins, carrying 
alanine substitutions, and analysing their DNA-binding properties. The results suggest that while both 
phenylalanine residues are important for PfTLP DNA-binding, only F60 is critical for stabilization of 
PfTLP/DNA complexes. Secondly, PfTLP possesses two low-complexity or intrinsically disordered 
regions (LCR1 and 2), which are absent in TLPs from model eukaryotes. These regions are located at 
the same positions within the two quasi-symmetrical repeats of the TLP core structure and show a 
non-random compositional bias towards a limited set of amino acids.  A growing body of evidence 
supports the idea that low complexity or intrinsically disordered proteins mediate liquid-liquid phase 
separation (LLPS) (Alberti et al., 2019; Brangwynne et al., 2009; Elbaum-Garfinkle et al., 2015; Nott et 
al., 2015). Bioinformatic analysis revealed that PfTLP LCRs are enriched in asparagine and lysine, and 
that these regions are well conserved throughout Plasmodium TLPs. PfTLP LCRs were fused to 
fluorescent proteins and the fusion proteins were functionally characterized in liquid-liquid phase 
separating assays. The results demonstrate that PfTLP LCR1 is capable of mediating LLPS, at least under 
certain conditions in vitro.  
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Chapter 1  
Introduction  
1.1 Plasmodium falciparum  
1.1.1 Impact  
Human malaria is caused by five species of Plasmodium: P. vivax, P. falciparum, P. ovale  
P. malariae, and P. knowlesi. Out of these species, the majority of malaria cases are caused 
by P. falciparum, which is predominantly found in Africa. P. falciparum is also the most severe 
form of malaria, with complications such as severe anaemia, cerebral malaria, coma, 
pulmonary edema, renal failure, ruptured spleen, and lactic acidosis (Hermansyah et al., 2017; 
Idro et al., 2005; Sheehy and Reba, 1967; Trampuz et al., 2003).  
World-wide there were 219 million cases of malaria in 2017, with 91 % of cases caused by  
P. falciparum in the African region (World Health Organization, 2018).  Children under the age 
of five are the most vulnerable group, and account for roughly 61 % of the over 400, 000 
malaria-related deaths. Despite massive global efforts, no significant progress was made 
towards the reduction of malaria cases between 2015 and 2017 (World Health Organization, 
2018). The challenges preventing the reduction of malaria include: lack of funding, drug and 
insecticide resistance, and lack of effective vaccines. The countries with the highest malaria 
burden are generally poor third-world countries who rely on external funding for the anti-
malaria programs and research. Multi-drug resistance, to both artemisinin and partner drugs, 
has been found in P. falciparum in the Greater Mekong Region (World Health Organization, 
2018).  Multi-insecticide resistant vectors have been found in all malaria-stricken regions 
world-wide.  Efforts to produce a viable vaccine have been met with serious challenges, 
mostly due to the great antigenic variation seen in Plasmodium (Cowman et al., 2012; World 
Health Organization, 2018).  
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1.1.2 Life Cycle  
Plasmodium forms part of the phylum Apicomplexa which includes parasitic protists that 
invade hosts using a specialized apical complex organelle (Aravind et al., 2003; Foth and 
McFadden, 2003). Most Apicomplexa have multiple hosts, and intricate life cycles which 
includes both sexual and asexual stages. P. falciparum infection of humans begins with the 
bite of an infected Anopheles mosquito, which injects small haploid sporozoites, present in 
the mosquito saliva, into the bloodstream. These infectious sporozoites travel to the liver 
where they invade hepatocytes, and undergo multiple asexual fission (schizogony) to produce 
exoerythrocytic merozoites, which are released into the bloodstream (Alano, 2007; Cowman 
et al., 2012; Willey et al.), where the merozoites will invade uninfected eryhtrocytes. Once 
inside the erythrocyte the plasmodial cell grows and develops into a trophozoite. The 
trophozoite’s nucleus divides asexually to produce a mature schizont which has multiple 
nuclei, the schizont then divides to produce mononucleated merozoites, which are released 
when the erythrocyte bursts. The merozoites go on to infect new red blood cells (Cowman et 
al., 2012; Crabb et al., 1996; Willey et al.). The erythocytic stage of the infection is cyclic and 
highly synchronized and repeats, in case of P. falciparum, every 48 hours. The release of 
toxins, merozoites and erythrocytic debris triggers the clinical symptoms of malaria infection 
(Willey et al.).  During the erythrocytic  asexual blood stage parasites may develop, at low 
frequency, from the ring stage into male and female gametocytes, which are instead ingested 
up by the feeding Anopheles mosquito (Alano, 2007; Cowman et al., 2012). In the mosquito 
gut gametocytes mature to form male and female gametes.  The gametes fuse to form a 
fertilized diploid zygote, which differentiates to form a motile ookinete, which develops into 
an oocyst in the mosquito gut. The oocyst undergoes meiosis (sporogony) to form 
sporozoites, which travel to the mosquito salivary glands (Alano, 2007; Aravind et al., 2003; 
Cowman et al., 2012; Crabb et al., 1996; Willey et al.). The infection cycle continues when the 
mosquito feeds on another human, injecting sporozoite carrying saliva into the new host  
(Fig. 1).  
 
 
 
12 
 
 
1.1.3 Gene Regulation  
In 2002 the genome of Plasmodium falciparum was sequenced and annotated (Gardner et al., 
2002). The 23-megabase nuclear genome is made of 14 chromosomes hosting predicted  
5300 genes. Strikingly, the genome consists of roughly 80% A/T bases.  Proteomic and 
transcriptomic studies established that the parasite sustains its intricate life cycle through a 
tightly regulated gene expression program (Bozdech et al., 2003; Florens et al., 2002; Horrocks 
et al., 2009).  During the intra-erythrocytic cycle in the human host, over 80% of P.falciparum’s 
genome is periodically regulated, in synchrony with the different developmental stages, as a 
continuous and highly coordinated cascade of gene expression. The repeating gene 
expression profile only  differentiates when the parasites enters gametogenesis at low 
frequency (Bozdech et al., 2003).  It was found that, during the gene expression program, 
Figure 1: Schematic of the Life Cycle of Plasmodium falciparum  
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gene clusters of proteins involved in similar cellular functions are co-expressed (Florens et al., 
2002; Horrocks et al., 2009; Le Roch, 2003). Furthermore, mRNAs from a particular cluster 
accumulate just prior to the cellular demands of a specific developmental stage. This 
observation led to the “just in time” hypothesis, which, assuming that translation immediately 
followed transcription, suggested that gene regulation occurred predominantly on at the level 
of transcription (Horrocks et al., 2009). However, later studies comparing mRNA and protein 
levels during various developmental stages revealed extensive post-transcriptional gene 
regulation, thereby opposing  the “just-in-time” hypothesis (Horrocks et al., 2009; Le Roch et 
al., 2004). 
Despite the differences in gene regulation between Plasmodium and model systems, there is 
evidence that gene regulation generally follows the principles established for model 
eukaryotes. Firstly, gene transcription is monocistronic and regulated by promoter regions 
and chromatin structure, (Lanzer et al., 1992b, 1992a). Secondly, the structure of transcribed 
mRNA resembles that of model eukaryotes, with a 5’ cap, a polyadenylated 3’ end and 
prototypical splice sites at intron/exon junctions. (Bischoff and Vaquero, 2010; Coleman and 
Duraisingh, 2008) 
Recent genome-wide mapping of transcription start sites provided first insights into the 
dynamics of RNA polymerase II transcription initiation during the  P. falciparum blood cycle in 
the human host (Adjalley et al., 2016). Transcription start sites (TSS) were found in closely 
spaced “clusters”, over a wide area upstream of the coding region, positioned less than 
 1000 bp from the start codon.  The paper found no evidence or signatures of a typical TATA 
box core promoter element directing transcription initiation 30 bp downstream (Adjalley et 
al., 2016). This finding, together with the observed diffuse TSS pattern might suggest two 
possibilities, which are not mutually exclusive. First, the RNA polymerase II pre-initiation 
complex (PIC) might be randomly positioned upstream of the gene coding region and initiates 
transcription about 30 bp downstream. Alternatively, specific core promoter regions that 
direct assembly of the PIC may exist but transcription is initiated at random positions at varied 
distances from the PIC,  similar to transcription initiation in S. cerevisiae (Adjalley et al., 2016)..  
Initially, the majority of transcription factors (TF), including general transcription factors, 
could not be identified in P. falciparum through conventional sequence homology searches 
(Gardner et al., 2002). This led to the assumption that there was a shortage of TFs in 
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 P. falciparum when compared to other model eukaryotes. This suggested that a large 
component of gene regulation had to be post-transcriptional or epigenetic (Coulson et al., 
2004). However, more P. falciparum TFs, including a proportion of the general transcription 
factors, were later identified in silico using a combination of profile-based searches and 
Hydrophobic Cluster Analysis (Callebaut et al., 2005).  Authors identified putative subunits of 
TFIIA, TFIIB, TFIIH, TFIIE and the TFIID subunits TAF1, TAF2, TAF7, and TAF10. Interestingly, 
TFIID subunits (TAFs) containing histone fold domains could not be identified, suggesting the 
possible existence of a unique TFIID complex architecture in P. falciparum (Callebaut et al., 
2005). Another Apicomplexan-specific class of transcription factors, ApiAP2, were also 
identified through sensitive sequence profile searches. The members of this class of 
transcription regulatory proteins are characterised by the presence of at least one AP2 
(Apetala 2) intergrase DNA binding domain, found in many plants. These TFs are found to be 
differentially expressed during the various parasite life stages (Balaji et al., 2005). Some 
members of this class of transcription factors has been well characterized both in vitro, and 
in cultured P. falciparum cells. The ApiAP2s class of transcription factors have been 
extensively reviewed (Jeninga et al., 2019; Llinás et al., 2008). Despite these discoveries,  
P. falciparum still appears to contain far fewer TFs than model eukaryotes. This might be 
because existing TFs diverged too far from established eukaryotic TFs, and can therefore not 
be detected using standard sequence-based methods. Alternatively, P. falciparum might 
function with a smaller set of TFs compared to other eukaryotes.  
Different to the apparent paucity of TFs in P. falciparum, a large number of chromatin-
structuring and remodelling proteins, as well as histone proteins were identified in 
 P. falciparum. Interestingly, P. falciparum possesses homologs for the canonical histone 
proteins H2A, H2B, H3 and H4, and the variant histones H2A.Z, H2Bv, H3.3 and CenH3  
(Coleman and Duraisingh, 2008; Cui and Miao, 2010) but lacks the gene for histone H1, which 
is important for higher-order nuclear organization and compaction (Cui and Miao, 2010) in 
eukaryotic model organisms. A large array of histone-modification enzymes and other 
chromatin-associated proteins have also been identified in Plasmodium (Coleman and 
Duraisingh, 2008). Furthermore, P. falciparum possesses a gene for a putative DNA 
methyltransferase, although there is no evidence for DNA methylation.  (Cui and Miao, 2010). 
Given the shortage of TFs and the abundance of chromatin-modifying factors, a large portion 
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of the gene regulation field focuses on chromatin modification and remodelling and 
epigenetics as methods of gene regulation (reviewed in Bischoff and Vaquero, 2010; Coleman 
and Duraisingh, 2008; Cui and Miao, 2010).  
1.1.4 Plasmodium falciparum Low-Complexity Regions 
Around 87% of P. falciparum genes contain one or more low-complexity regions (LCRs) 
(DePristo et al., 2006; Zilversmit et al., 2010). LCRs represent protein sequences with non-
random compositional bias towards a limited number of amino acids, and are usually 
intrinsically disordered non-globular domains (Zilversmit et al., 2010). LCRs within protein 
sequences can be computationally identified using the SEG algorithm developed by Wootton 
and Federhen (Wootton and Federhen, 1993).  
An initial bioinformatics analysis of the P. falciparum genome identified LCRs (PfLCRs) using 
the SEG algorithm as well as by sequence alignment of putative P. falciparum  proteins with 
eukaryotic homologs in chromosomes 2 and 3, where LCRs are identified as long stretches of 
amino acid insertions between globular domains  (Aravind et al., 2003; Pizzi and Frontali, 
2001). 90% of PfLCRs were found to be hydrophilic and represent rapidly evolving nonglobular 
domains with a possible function in antigenic variation and host immune system evasion 
(Brocchieri, 2001; Pizzi and Frontali, 2001). These hydrophilic LCRs were preferentially 
enriched in asparagine residues (Aravind et al., 2003; Brocchieri, 2001; Pizzi and Frontali, 
2001).  The amino acid bias in many P. falciparum LCRs appears to be the result of the 
extremely skewed genome composition towards A/T content and likely emerged and 
diverged through replication slippage and recombination events (Aravind et al., 2003; 
DePristo et al., 2006; Xue and Forsdyke, 2003; Zilversmit et al., 2010).   
Subsequent genome-wide studies identified three types of P.falciparum LCRs (Zilversmit et 
al., 2010). Firstly, heterogeneous PfLCRs, encoded by highly A/T-rich genome sequences, 
which appear to be aperiodic and slow evolving. Secondly, A/T-rich genomic sequences that 
contain multiple trinucleotide repeats coding for the amino acid asparagine, known as poly N 
sequences. Finally, LCRs stemming from genomic sequences with high G/C content, created 
through frequent recombination events (Aravind et al., 2003; Zilversmit et al., 2010).  
The abundance of asparagine in PfLCRs strongly suggested the presence of prion-like domains 
in these intrinsically disordered domains. Prion-like domains (PrLDs) are amino acid 
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sequences enriched in glutamine (Q) and asparagine (N) with set sequential and structural 
characteristics that confer the ability to adopt different conformational states and the 
propensity to form amyloids (Pallarès et al., 2018). PrLDs were found in roughly 10% of the P. 
falciparum genome (Pallarès et al., 2018). Because cells generally select against proteins with 
aggregation-prone sequences, the conservation of PrLDs suggest they might have important 
functional roles (Pallarès et al., 2018).  
1.2 Eukaryotic Transcription  
Transcription initiation is regulated through various means and mechanisms. Briefly, 
chromatin structure is modified to create nucleosome-free promoters and enhancer DNA 
sequences, which will interact with transcription factors, activators, and coactivators to 
generate an active transcriptional state (Cramer, 2019; Haberle and Stark, 2018).  
Chromatin structure needs to be manipulated so that active promoters are accessible to the 
transcription apparatus, and this is achieved by the removal or shifting of nucleosomes.  The 
accessibility of a given DNA sequence is dependent on the action of chromatin remodelling 
factors, as well as the readout of histone modifications and DNA methylation (Cramer, 2019; 
Haberle and Stark, 2018). The accessible promoter sequences are situated in the vicinity of 
the transcription start sites (TSS) and interact with the basal transcription machinery to form 
the preinitiation complex (PIC), which allows transcription to start. Promoter sequences often 
contain specific DNA sequence elements, called core promoter elements, which are 
recognized by the basal, or general, transcription factors (GTFs). Some promoters lack defined 
sequence elements, suggesting promoter recognition by transcription factors occurs through 
indirect readout, whereby proteins recognize physical properties of DNA sequences, such as 
bendability. Alternatively, binding sites may be demarcated by nucleosome-free regions 
flanked by positioned nucleosomes, such as +1 nucleosome found immediately upstream of 
the transcription start site (Cramer, 2019; Haberle and Stark, 2018). Distal (enhancer) 
regulatory sequences modulate the activity of the core promoter and basal transcription 
factors and stimulate the assembly of the PIC at the transcription start site. These enhancer 
sequences contain binding sites for sequence-specific transcription regulatory proteins, such 
as repressors and activators.  The function of activators are mediated by coactivators such as 
the Mediator complex, which links transcription factors with the PIC. Enhancers communicate 
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with target genes through proximity, which is governed by chromatin architecture (Cramer, 
2019; Haberle and Stark, 2018). Some TFs are referred to as pioneer factors, based on their 
ability to bind to nucleosomal DNA and to recruit histone modifying and chromatin 
remodelling factors, which in turn remodel chromatin architecture to make promoter 
sequence accessible (Cramer, 2019; Haberle and Stark, 2018). Together, these means of gene 
regulation converge on the formation of the preinitiation complex (PIC) by the general 
transcription machinery (GTFs), which is the ultimate target for gene expression pathways 
(Haberle and Stark, 2018).  
1.2.1 RNA Polymerase  
The process of transcription is dependent on the enzyme RNA polymerase, which converts 
information from DNA into RNA. In eukaryotes four classes of RNA polymerase have been 
identified: RNA polymerases I, II, III, and IV. Only one RNA polymerase has been found in 
prokaryotes. The RNA polymerases in eukaryotes have different biochemical properties, 
cellular localizations, and mostly function in a nonredundant manner (Roeder and Rutter 
1970; Thomas and Chiang 2006). RNA polymerase I is found in the nucleoli and synthesizes 
18S and 28S rRNA. RNA polymerase II transcribes mostly mRNA and is found in the 
nucleoplasm together with RNA polymerase III, which transcribes 5S rRNA and tRNA. The 
fourth RNA polymerase was identified in plants and is in control of the synthesis of siRNA 
(Thomas and Chiang 2006). RNA polymerases lack sequence-specific DNA binding activity and 
require general transcription factors (GTFs) to recognize and bind promoter sequences.  
1.2.2 RNA Polymerase II general transcription factors  
General transcription factors function to recruit RNAP-II to the core promoter and to 
assemble with RNAPII to form a so-called preinitation complex (PIC), required for 
transcription initiation. They include transcription factors II A (TFIIA), -IIB, -IID, -IIE, -IIF, and 
TFIIH. The PIC may form in either a sequential or two -step manner. In the sequential step-
wise assembly the promoter region is recognized and bound by TFIID, and the PIC is formed 
by step-wise association of TFIIA, TFIIB, RNAP-II, TFIIF, TFIIE and TFIIH. In the two-step 
assembly model a complex of TFIID and TFIIA will bind the promoter region and then recruit 
a pre-assembled RNAPII holoenzyme containing the remaining GTFs required for transcription 
initiation  (Akhtar and Veenstra, 2011; Thomas and Chiang, 2006; Zehavi et al., 2015).   
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1.2.3 Core Promoters 
Core promoters span a region of roughly 100 bp around a TSS. Core promoters are generally 
nucleosome free and accessible to the transcription machinery, and contain specific sequence 
elements. These core promoter sequence elements are recognized by components of the 
general RNAPII transcription machinery to recruit and position the RNAPII transcription 
initiation complex (PIC) and to determine the location of the transcription start site (reviewed 
in Haberle and Stark, 2018; Kadonaga, 2012; Smale and Kadonaga, 2003). Several core 
promoter elements have been identified in model eukaryotes, such as:  
The TATA-box element, which is found in a small subset of genes, has the consensus sequence 
of TATA(A/T)A(A/T)(A/G), and is recognized and bound by the TATA-box binding protein (TBP), 
which forms part of the TFIID complex (Haberle and Stark, 2018). The TATA-box is usually 
found between nucleotide positions -31 and -24 upstream of the TSS. The binding of TBP to 
the TATA-box element is the initial step in the sequential PIC formation (Thomas and Chiang, 
2006). Additional core promoter elements that have been identified in eukaryotes include the 
upstream and downstream TFIIB Recognition Element (BREU/BRED), the initiator (Inr) 
sequence, the downstream promoter element (DPE), the motif ten element (MTE) the 
downstream core element (DCE). Core promoters are complex in that they contain several 
core promoter sequence elements, in various combinations, and that there is a large degree 
of structural diversity between core promoters. Importantly, none of the core promoter 
elements identified to date is universally required for transcription initiation. Finally, core 
promoter regions of many genes appear not to contain any of the known core promoter 
elements, suggesting that there might be additional sequence elements yet to be discovered 
(Haberle and Stark, 2018; Lee et al., 2005; Thomas and Chiang, 2006; Vo ngoc et al., 2017).  
1.2.4 TATA-box Binding Protein  
The TATA-box binding protein (TBP) is a key component of the TFIID complex and is 
responsible for recognizing and binding the TATA box promoter element. TBP is well 
conserved from archaea to man and is the founding member of a class of paralogue 
eukaryotic proteins.  
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The structure of TBP can divided into two parts, a conserved core C-terminal domain and a 
variable N-terminal domain. The C-terminal core structure adopts a saddle-like shape, made 
up of two pseudo-symmetric halves. The core domain consists of four α-helices which connect 
the two halves, and ten β-strands that make contact with the DNA (Fig. 2; Kim and Burley, 
1994; Kim et al., 1993; Nikolov et al., 1992, 1996, 2002). The crystal structures of human, 
yeast, and Arabidopsis TBP bound to the TATA box revealed the DNA binding mechanism of 
TBP.  TBP unwinds the DNA as the concave part of the saddle structure binds to the minor 
groove, interacting with the edges of the base pairs. Through a two-step induced-fit 
mechanism, TBP severely bends the TATA box sequence after the initial binding event. The 
DNA-bending caused by TBP results from the action of four conserved phenylalanine residues. 
Two of these residues intercalate between bases 1 and 2 and between 7 and 8 of the TATA 
box sequence, causing DNA kinking (Fig. 2), while the other two residues stabilize  base 
intercalation (Kim et al., 1993; Nikolov et al., 1992, 2002). Mutational analysis of human TBP 
showed that substitution of these phenylalanine residues (F197, F214, F288, and 305 in 
HsTBP) results in loss of TBP TATA box binding activity (Klejman et al., 2005; Zhao et al., 2003). 
Like any other DNA-binding protein, TBP also possess non-specific DNA-binding activity 
(Coleman and Pugh, 1995). It has been shown that the TATA-specific DNA binding activity of 
TBP is not required for transcription form TATA-less promoters (Martinez et al., 1995).  
The convex side of the saddle shaped C-terminal domain mediates most of the TBP 
interactions with protein binding partners, such as TFIIB and TFIIA, and residues involved in 
these interactions have been shown to be well conserved (Thomas and Chiang 2006). In 
contrast to the C-terminal DNA-binding domain, the unstructured N-terminal portion of TBP 
is not conserved in sequence or length from species to species and its function is not well 
understood. (Akhtar and Veenstra, 2011; Thomas and Chiang, 2006; Zehavi et al., 2015).   
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Figure 2: Crystal structure of human TBP bound to the minor groove of the TATA box 
promoter element. The x-ray structure model of the human TBP/TATA complex (PDB 
accession 1C9B)  was rendered using UCSF Chimera (Pettersen et al., 2004). The HsTBP 
saddle-shaped core domain is shown as a cartoon model in cyan with evolutionary 
conserved phenylalanine residues highlighted. Intercalating phenylalanine residues are 
shown in red and supporting phenylalanine residues in yellow. The TATA box DNA in the 
complex is shown in grey. The model in the lower panel is rotated by 90˚ about the 
horizontal axis towards the viewer compared to the model shown above 
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1.2.5 TBP-like Protein (TLP)  
Metazoans possess TBP paralogues, called TBP-like proteins (TLPs) or TBP-related factors 
(TRFs).  Some of these TLPs are well characterized in model eukaryotic organisms and are 
thought to be involved in cell type-specific transcription and in development and 
differentiation.   
TRF1 was the first TLP to be identified (Holmes and Tjian, 2000), and is specifically found in 
insects, where it is required for RNA polymerase III transcription from most (Takada et al., 
2000) but not all (Verma et al., 2013) promoters.  
TFR3-type TLPs are found in vertebrates and are most closely related to TBP, sharing roughly 
93% amino acid sequence homology. TRF3 has been shown to interact with both TFIIB and 
TFIIA, to have TATA box-binding activity, and to nucleate the RNA Polymerase II PIC (Akhtar 
and Veenstra, 2011; Bártfai et al., 2004; Zehavi et al., 2015). The precise function of TRF3-type 
TLPs has not been fully elucidated, but they appear to play species-specific roles in cell 
differentiation and development. In Xenopus laevis, TRF3 is predominantly expressed in 
oocytes, which appear to contain very little to no TBP, and is responsible for a large subset of 
vital genes during embryogenesis (Jallow et al., 2004). Consistent with this, knock-out of TRF3 
in mice results in female sterility, due to the loss of transcription from oocyte-specific genes 
(Gazdag et al., 2009). In zebrafish, TRF3 knockout results in a phenotype consistent with mis-
regulation of embryonic patterning (Bártfai et al., 2004).   
To date, TRF2-type TLPs are by far the best characterized TLPs. TRF2s share about 60% 
homology to TBP and are found throughout multicellular organisms, in every cell type. TRF2s 
are predicted to adopt the same saddle-shaped core domain as TBP. While amino acid 
residues mediating interactions with TFIIA and TFIIB appear to be conserved, TRF2-type TLPs 
contain substitutions at amino acid positions critical for TBP DNA-binding activity including 
the critical phenylalanine residues involved in TATA box binding. Consistent with this, TRF2s 
appear to lack sequence-specific DNA-binding activity (Akhtar and Veenstra, 2011; Berk, 
2000; Duttke et al., 2014; Thomas and Chiang, 2006; Wang et al., 2007; Zehavi et al., 2015).  
TRF2 has different functions to that of TBP, and nucleate the PIC on promoters distinct from 
those of TBP (Akhtar and Veenstra, 2011; Berk, 2000; Zehavi et al., 2015). For example, TRF2 
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was shown to be involved in the regulation of TATA-less G/C-rich promoters of ribosomal 
proteins (Isogai et al., 2007; Wang et al., 2007). Additionally, in Drosophila TRF2 mediates 
transcription from DPE-containing promoters (Kedmi et al., 2014).  
TRF2 has, in some cases, been shown to regulate proteins involved in chromatin structure. 
For example, it has been shown to regulate the histone H1 TATA-less promoters. Additionally, 
in Drosophila, TRF2 co-purified with the nucleosome remodelling factor (NURF) and the 
DNA-replication related element-binding factor (DREF), and directs core promoter 
recognition of the proliferating cell nuclear antigen (PCNA) gene via a TRF2-DREF complex 
(Hochheimer et al., 2002).  Furthermore, TRF2 depletion resulted in structural defects of 
polytene chromosomes  (Isogai et al., 2007). 
Multiple studies in eukaryotic model organisms have shown that TRF2 might be important for 
embryogenesis. For example, in Caenorhabditis elegans, TRF2 is expressed at similar levels as 
TBP, and is responsible for the regulation of a large subset of genes involved in embryonic 
development, such as early patterning genes  (Dantonel et al., 2000; Kaltenbach et al., 2000). 
Furthermore, in Xenopus laevis, TRF2 is important for the transcription of a subset of genes 
involved in embryo catabolism (Jacobi et al., 2007; Veenstra et al., 2000). In zebrafish, 
depletion of TRF2 in embryos resulted in downregulation of specific regulatory genes and 
gastrulation failure (Müller et al., 2001). Mutational studies suggested that TRF2 also plays an 
important role in Drosophila embryogenesis (Kopytova et al., 2006). In contrast, TRF2 is not 
required for embryonic development in mice (Akhtar and Veenstra, 2011; Zehavi et al., 2015). 
TRF2 is also important for cell type specific differentiation. For example, in mice a TRF2 
deficiency had no effect on viability, but the male mice were sterile, due to an arrest of late 
spermiogenesis (Martianov et al., 2002; Zhang et al., 2001). Furthermore, in Drosophila, TLP 
mutations led a reduction of gene expression of ecdysone-controlled genes, which are 
essential for proper metamorphosis (Bashirullah et al., 2007) .  
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1.3 Liquid-Liquid Phase Separation  
1.3.1 Membraneless Organelles  
Cells can organize reactions and processes using membrane bound organelles, such as the 
mitochondria or the nucleus. However, cells can also form membraneless organelles lacking 
a delimiting membrane, such as the nucleolus, stress granules, P-granules, Cajal bodies, and 
the centriole (Boeynaems et al., 2018). A landmark paper by Brangwynne et al (2009) showed 
that P-granules have liquid like properties; they are spherical droplets capable of fusing, 
dripping, deforming under shear stress, and show fast internal reorganization (Brangwynne 
et al., 2009; Gomes and Shorter, 2019). This discovery led to a large body of study that 
established that membraneless organelles can be described as biomolecular condensates that 
can be understood as liquid droplets that form through liquid-liquid phase separation 
(Boeynaems et al., 2018; Gomes and Shorter, 2019).  
1.3.2 Liquid-Liquid Phase Separation  
Liquid-liquid phase separation (LLPS) occurs when a homogenously mixed liquid solution 
separates into two distinct liquid phases, or regions of space with distinct concentration of 
molecules. LLPS is a well-known phenomenon in polymer chemistry and physics, but has only 
recently been studied with complex biomolecules (Boeynaems et al., 2018). 
The physics underlying LLPS has been extensively reviewed (Bergeron-Sandoval and Michnick, 
2018; Boeynaems et al., 2018; Martin and Mittag, 2018; Zhou et al., 2018). Briefly, LLPS is 
driven by the lowering of free energy of mixing, given by the equation:  
∆𝐺𝑚 =  ∆𝐻𝑚  − 𝑇∆𝑆𝑚 
ΔSm represents the entropy of mixing and is described by the Flory and Huggins equation of 
an ideal polymer (Boeynaems et al., 2018; Martin and Mittag, 2018), which is based on the 
volume fractions occupied by both polymer and solvent. The larger the polymer, the lower 
the entropic cost of confining the polymer in a dense phase. This in turn means that an 
increase in polymer size will decrease the concentration at which it phase separates. ΔHm 
represents the enthalpic component of mixing, and is described by the mean field theory, 
which is based on the comparison of the interactions between solvent-solvent, polymer-
24 
 
polymer and solvent-polymer. This gives rise to an interaction parameter. Taken together, 
these two equations can be combined into the free energy of mixing equation to form the 
Flory-Huggins Expression. The expression denotes that the entropy of mixing is always 
positive. However, when polymer-polymer interactions are favoured, energy minima or 
inflection points are created within the free energy curve, which represent points at which 
the solution is unstable and can de-mix into polymer dense and light phases (Martin and 
Mittag, 2018).  
The Flory-Huggins expression fails to account for sequence dependent interactions of 
heteropolymers. It also fails to explain more complicated entropic effects. Entropy inherently 
favours mixing, and this is even more favourable at higher temperatures. However, for 
hydrophobic polymers there is a gain of entropy at higher temperatures as polymers are 
compacted and solvent molecules are released. These are known as lower critical solution 
temperature (LCST) polymers, as they phase separate at higher temperatures due to an 
entropic gain. On the other hand upper critical solution temperature (UCST) polymers phase 
separate at lower temperatures due to molecular interactions (Martin and Mittag, 2018). 
Phase separation can be distinguished from aggregates on the basis of thermodynamic 
reversibility, wherein phase separated droplets can dissolve again based on a change in 
signalling parameters (Zhou et al., 2018).  
Phase separation can be driven by proteins or nucleic acids that are known as “scaffolds”, in 
which multivalency of so-called “adhesive domains” is a key feature. Multivalency can be 
achieved in numerous ways. Firstly, through folded protein domains that facilitate protein-
protein interactions. Secondly, through folded domains that can be linearized through linkers. 
Finally, through intrinsically disordered low-complexity regions (IDRs, LCRs), which are 
hallmarked by conformational heterogeneity and a non-random compositional bias towards 
a limited number of amino acids. IDRs/LCRs can contain stretches of hydrophobic, polar, 
charged or aromatic residues that form small linear motifs (SLiMs), charge blocks, or 
degenerate repeats, which act as adhesive patches that facilitate interactions (Boeynaems et 
al., 2018; Martin and Mittag, 2018; Wheeler and Hyman, 2018). Interactions between scaffold 
proteins needs to be strong enough to support a dense phase, and, at the same time, be 
dynamic and transient enough to form a liquid and not an aggregate. These interactions 
include electrostatic, dipole-dipole, π - π, cation – π and hydrophobic interactions, as well as 
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hydrogen bonding (Boeynaems et al., 2018; Gomes and Shorter, 2019; Martin and Mittag, 
2018; Zhou et al., 2018). The differences in solution properties and behaviours of dense 
phases depend on the primary sequence of the scaffold.  RNA can also act as a scaffold, by 
acting as a binding partner to proteins containing an RNA-binding domain (RBD), or through 
intermolecular base pairing that promotes phase separation (Boeynaems et al., 2018).  
1.3.3 Regulation of Liquid-Liquid Phase Separation  
Many proteins have been shown to be capable of LLPS, and cells need to tightly control this 
process to ensure appropriate cellular functions (Alberti, 2017; Franzmann and Alberti, 2019). 
LLPS is highly sensitive to environmental conditions and cellular signals, because the system 
functions at the hypersensitive phase boundary, where small changes can induce phase 
transition, which in turn can result in a system-wide response at little to no energy 
expenditure. This makes LLPS an appealing means of cellular organization and regulation 
(Alberti, 2017; Franzmann and Alberti, 2019; Yoo et al., 2019). Changes in osmotic pressure, 
pH, temperature, salt, and protein concentration can induce or dissolve LLPS droplets (Zhou 
et al., 2018). One example is the yeast protein Sup35, which undergoes LLPS in response to a 
decrease of cellular pH under stress (Franzmann et al., 2018; Ruff et al., 2018). Another 
example is the poly (A)-binding protein Pab1, which binds heat shock chaperone 3’ mRNA 
ends. In response to elevated temperatures, Pab1 releases bound RNA and phase separates. 
This allows the translation of heat shock chaperones in response to heat stress.  In turn, these 
chaperones then help to dissolve the phase separated Pab1 droplets, returning the cell to its 
default state (Riback et al., 2017; Ruff et al., 2018).  
Post-translational modifications (PTM) also play an important role in regulating the LLPS 
behaviour of scaffold proteins. PTM of the IDR/LCRs changes intrinsic sequence properties 
and intermolecular interactions potential, thereby changing the LLPS behaviour (Boeynaems 
et al., 2018; Zhou et al., 2018). Multiple studies have demonstrated that changes in the 
phosphorylation status affect LLPS of IDRs/LCRs, and that phosphorylation of even a single 
serine residue in a scaffold IDR/LCR can modulate LLPS (Aumiller and Keating, 2016; Guo et 
al., 2019). Therefore, LLPS can be dependent on the activity levels of kinases and 
phosphatases involved in regulating the phosphorylation level of scaffold proteins (Li et al., 
2012). Another example for regulation of LLPS by PTM is the methylation of arginine residues 
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in the RNA-binding protein hnRNAP2, which was shown to completely disrupt LLPS (Ryan et 
al., 2018). SUMOylation has also been shown to be involved in LLPS regulation, where 
SUMOylation of promyelocytic leukemia protein (PML) is required for the formation of 
nuclear bodies (Shen et al., 2006). Finally, poly (ADP) ribosylation induces LLPS of proteins like 
Fused in Sarcoma protein (FUS) and TAR DNA-binding protein 43 (TDP-43) (Altmeyer et al., 
2015; Gomes and Shorter, 2019).  
RNA is a major component of many membrane-less organelles, suggesting that it likely plays 
a major role in regulating LLPS. Many coding and noncoding RNAs can nucleate the formation 
of nuclear bodies, such as Men ϵ / β noncoding RNA, which nucleates the formation of nuclear 
speckles (Gomes and Shorter, 2019; Shevtsov and Dundr, 2011). Some proteins can compete 
with droplet-forming proteins for RNA-binding partners, thereby regulating LLPS of those 
proteins (Zhou et al., 2018). Furthermore, RNA has been shown to both promote and limit 
LLPS, as in the case of Pab1 (Boeynaems et al., 2018; Riback et al., 2017). 
Finally,  nuclear transport systems controls both the concentration and localization of scaffold 
proteins and RNA which in turn regulates LLPS and pathological protein aggregation 
(Boeynaems et al., 2016, 2018).  
1.3.4 Functions of Membraneless Organelles 
The full repertoire of the cellular functions of LLPS and membrane-less organelles is only 
starting to be explored. Current literature has implicated LLPS in cellular sensing, protein 
concentration buffering, concentration, localization and sequestering of molecules, 
mechanical driving forces, physiochemical filtering and gene regulation.  
Because LLPS events are highly sensitive to parameters such as pH, temperature, and salt 
concentrations, LLPS formation can be exploited by the cell to sense and respond to changes 
in the environment. It has already been shown that Pab1 acts as a sensor for cellular stress 
such as temperature (vide supra; Riback et al., 2017). Likewise, the Saccharomyces cerevisiae 
eukaryotic translation release factor 3 (Sup35) phase separates at low pH conditions, thereby 
protecting itself during cellular stress and acting as a cellular sensor (Franzmann et al., 2018).  
Phase-separated droplets can also be used to buffer protein concentrations. The 
concentration of a particular protein can be kept constant in the dilute phase, as a rise in 
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concentration can be buffered by including protein in the dense droplets, thereby increasing 
their volume. As the concentration in the dilute phase drops, proteins are released from the 
dense droplets to restore the equilibrium (Alberti et al., 2019).  
LLPS can also be used by the cell as a means of concentrating molecules. The multi-protein 
assembly miSISC concentrates molecules in order to facilitate RNA processing. miSISC uses 
microRNA to identify mRNA that needs to be suppressed, it then phase separates and recruits 
deadenylation factors into the droplet to facilitate decapping of mRNA (Sheu-Gruttadauria 
and Macrae, 2018). The pre-centriolar material scaffold proteins forms phase separated 
droplets that recruit other proteins and tubulin into the droplet where it is concentrated 
enough to nucleate microtubule asters (Woodruff et al., 2017). Phase separation can also be 
a means to suppress reactions by sequestering key molecules into droplets, preventing their 
entry into specific pathways (Alberti et al., 2019). LLPS Droplets can selectively recruit specific 
proteins and RNA species, while excluding others (Alberti et al., 2019). For example, stress 
granules recruit the proteosomal shuttle factor UBQLNZ to droplets, wherein the factor 
interacts with ubiquitinated substrates to reverse the LLPS and enable the release of client 
proteins from the droplets (Dao et al., 2018).  
Phase separated droplets can also be used to exert mechanical force within the cell. 
Interactions of phase-separated proteins can result in deformation of the cellular plasma 
membrane, thereby facilitating endocytosis (Bergeron-Sandoval et al. 2017). There is also 
evidence that LLPS can also be used to construct physiochemical sieves within the cell. 
Nuclear pore complexes form hydrogel sieves through LLPS of LCRs, that act as barriers that 
selectively allows the active transport of specific molecules (Schmidt and Görlich, 2016).  
Recently, LLPS has been shown to be an important component of gene regulation. It was 
shown that heterochromatin has liquid droplet-like properties and likely forms via LLPS 
(Larson and Narlikar, 2018). Another aspect of gene regulation that has been linked to phase 
separation is the action of super enhancers. The Mediator subunit MED1 can undergo LLPS at 
super enhancers, and, in doing so,  recruit and concentrate the transcription apparatus (Sabari 
et al., 2018). The super enhancer target genes can associate with these condensates during 
transcription activation (Chong et al., 2018; Hnisz et al., 2017; Sabari et al., 2018; Shrinivas et 
al., 2019). The C-terminal domain (CTD) of RNA Polymerase II can also form liquid-like 
condensates with the mediator complex; this, however, is dependent on its phosphorylation 
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state (Chong et al., 2018; Guo et al., 2019; Gurumurthy et al., 2019).  Finally, activator domains 
of transcription factors such as octamer-binding transcription factor 4 (OCT4) and GCN4, form 
phase-separated droplets with the mediator complex during gene activation.  Furthermore, 
estrogen enhances the phase separation of droplets containing the estrogen receptor and 
mediator complex (Boija et al., 2018; Hahn, 2018).  How these condensates recruit the basal 
RNA polymerase II transcription machinery to facilitate PIC assembly at target genes is not 
fully understood. So far, there has been no evidence implicating GTFs in LLPS (Gurumurthy et 
al., 2019; Sabari et al., 2018).   
Aim and Objectives  
 
Currently there is a lack of literature pertaining to the molecular mechanisms governing 
transcription regulation in P. falciparum. To bridge this gap in current knowledge our research 
group aims to functionally characterize P. falciparum GTFs in order to elucidate the molecular 
mechanisms underlying gene regulation at the level of transcription initiation in this globally 
important parasite. This includes characterization of the DNA-binding activity of P. falciparum 
GTFs, as well as the determination of specific promoter sequence elements. Recently, the 
research group also started investigating the possible involvement of liquid-liquid phase 
separation (LLPS).  
The aim of this study was to functionally characterize P. falciparum TBP-like protein (PfTLP). 
The work included bioinformatics analyses, characterization of the DNA-binding activity of 
bacterially expressed recombinant PfTLP proteins, and the investigation of a potential role of 
PfTLP low-complexity regions in driving LLPS.  
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Chapter 2 
Materials and Methods 
2.1 Bioinformatics  
Multiple sequence alignments were done using the programs  Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/; Sievers et al., 2014) or Muscle 
(https://www.ebi.ac.uk/Tools/msa/muscle/; Edgar, 2004), with default settings on the EMBL-
EBI web-based platform (https://www.ebi.ac.uk/Tools/msa/;  Madeira et al., 2019). Results 
of multiple sequence alignments were visualized using UGENE (http://ugene.net; 
Okonechnikov et al., 2012). Phylogenetic trees were generated using LIRMM – Phylogeny 
(http://phylogeny.lirmm.fr/phylo_cgi/index.cgi; Dereeper et al., 2008). Three-dimensional 
structure predictions were generated using Phyre 2.0 (http://www.sbg.bio.ic.ac.uk/~phyre2/; 
Kelley et al., 2015), and the resulting 3D structure models were visualised using UCSF Chimera 
1.13 (https://www.cgl.ucsf.edu/chimera/; Pettersen et al., 2004). General protein statistics, 
including amino acid percentage use, pI and molecular weight,  were calculated using the 
ProtoParam tool on the ExPasy server ( https://web.expasy.org/protparam/; Gasteiger et al., 
2005). Disorder predictions were carried out using the DisMeta disorder prediction server 
(http://www-nmr.cabm.rutgers.edu/bioinformatics/disorder/; Huang, Acton & Montelione, 
2014) 
2.2 Expression of Recombinant PfTLP Proteins in Escherichia 
coli 
2.2.1 Plasmids  
The expression vectors pET11d-6His-PfTLP, -F60A, -F283A and -F60&238A were cloned by 
David Adebolajo, a previous laboratory member (Adebolajo, 2016). The pET11d-6His vectors 
are derivatives of the pET11d (Novagen®) plasmid developed for expression of recombinant 
proteins carrying an N-terminal six histidine tag (Hoffmann and Roeder, 1991).   
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2.2.2 Transformation   
100 µL BL-21-CodonPlus®(DE3)-RIL competent E. coli cells (Agilent Technologies) were 
incubated on ice for 45 minutes with 100 ng of plasmid, followed by heat shock at 42 ⁰C for 
90 seconds, and cooling on ice for 2 minutes. 900 µL SOC medium (0.5% (w/v) yeast extract, 
2.5 mM KCl, 10 mM MgCl2, 10 mM NaCl, 2% (w/v) tryptone,  10 mM MgSO4, 20 mM glucose) 
was added and the cells were incubated at 37⁰C with shaking for 1 h.  100 – 200 µL were 
plated onto LB agar plates (100 μg/ml ampicillin (AMP), 34 μg/ml chloramphenicol (CAM)) 
and incubated at 37⁰C for 16 hours.  
2.2.3 Production of Glycerol Cell Stocks   
Glycerol stocks of transformed bacteria were generated for long-term storage at -80 ⁰C by 
mixing one volume of bacteria at logarithmic growth (OD600 0.3 – 0.5) with one volume ice-
cold 60% glycerol and snap-freezing in liquid nitrogen.  
2.2.4 Expression of Recombinant PfTLP in E.coli 
The growth medium used in expression experiments was lysogeny broth (LB) (1% (w/v) 
tryptone, 0.5% (w/v) yeast extract, and 170 mM NaCl) supplemented with 100 μg/ml AMP, 
34 μg/ml CAM, and 1% (w/v) glucose. Cells from a freshly transformed plate or glycerol stock 
were used to inoculate a starter culture, which was incubated for 16 h at 37 ⁰C with shaking. 
The culture was centrifuged at ~3000 xg for 10 min, and cell pellets resuspended in fresh 
media to remove β-lactamase activity. Freshly resuspended cells were used to inoculate a 
larger culture volume. The culture was then incubated at 37 ⁰C with shaking until the OD600 
reaches 0.5. The cultures were then cold-shocked in an ice slurry and cooled down to 25 ⁰C. 
Isopropyl β-D-1-thiogalactopyranoside (IPGT) was added to 500 µM to induce expression and 
cultures were further incubated for 3 h at 25 ⁰C. Finally, the cells were harvested by 
centrifuging at ~3000 xg for 10 min.  
Large scale expression was carried out using 3 L of culture, divided into five 600 ml cultures. 
Each 600 ml culture was inoculated with 20 ml of freshly resuspended overnight culture.   
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2.3 Purification of Recombinant PfTLPs 
All purification and chromatography steps were carried out at 4 ⁰C. During pilot experiments 
it became clear that PfTLP tends to binds to the walls of plastic reaction tubes, which led to 
low yield. For this reason, protein purification was carried out using LoBind (Protein) 
Eppendorf® tubes.  
2.3.1  Production of Clear Lysate 
Collected bacterial cell pellets were left overnight on ice. The next day, every 1 g of cell pellet 
(wet weight) was resuspended in 5 ml of sonication buffer (50 mM Tris-HCl pH 7.9 @ 4˚C,  
20 mM imidazole, 500 mM NaCl, 0.1 % NP-40)  containing 25 μl protease inhibitor cocktail 
(Sigma-Aldrich® P8849) and 1 μg/μl lysozyme from chicken egg white (Sigma-Aldrich® 62971). 
The cells were sonicated six times with a 10 s pulse, followed by 30 s cooling on ice. After 
sonication, cell lysates were incubated on ice for 1 h with 250 U of Benzonase®Nuclease 
(Sigma-Aldrich® E1014), followed by centrifugation at 26,000 xg for 35 min at 4 ⁰C. The 
supernatant was collected as cleared lysate and the pellet as insoluble fraction.  
2.3.2 Metal Affinity Chromatography 
Metal-affinity purification was carried out in a Poly-Prep® chromatography column (Bio-Rad). 
300 μl packed resin volume of TALON® Metal Affinity Resin (Clontech) was equilibrated with 
10 ml sonication buffer. After loading the cleared lysate, unbound material was removed and 
the salt concentration adjusted by step-wise washing with 2 ml wash buffers 1-4 (20 mM  
Tris-HCl pH 7.9 @4˚C, 20 mM imidazole, 0.2 mM EDTA pH 8, 0.1 % NP-40) containing 
decreasing NaCl concentrations of 400 mM, 300 mM, 200 mM and 100 mM, respectively.  
NaCl was then exchanged for KCl, with  a 5 ml wash using BC-buffer (20 mM Tris-HCl pH 7.9 
@ 4⁰C, 0.2 mM EDTA pH 8, 0.1 % NP-40, 10 mM β-mercaptoethanol, 20 % glycerol) containing 
100 mM KCl. Finally, bound protein was eluted in 10 ml BC-buffer containing 100 mM KCl and 
250 mM imidazole. 300 μl fractions were collected in LoBind (Protein) Eppendorf® tubes, snap 
frozen in liquid nitrogen and stored at -80 ⁰C. 
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2.3.3 Cation-Exchange Chromatography 
650 μl of SP sepharose FF® (Sigma-Aldrich®) was packed in a Poly-Prep® Chromatography 
Column (Bio-Rad) and equilibrated with BC-buffer containing 100 mM KCl (BC-100). Cobalt 
affinity chromatography elution fractions with the highest protein concentration were loaded 
onto the column and unbound protein washed out with 8 column volumes of BC-100 buffer. 
Proteins were eluted, at a flow rate of 30 column volumes per hour, with a BC-buffer salt 
gradient from 100 mM to 500 mM KCl over 20 column volumes followed by a final elution 
step with 5 column volumes of BC-buffer containing 500 mM KCl (BC-500).  300 μl elution 
fractions were collected, snap frozen and stored at -80 ⁰C. SDS PAGE analysis of elution 
fraction showed that recombinant PfTLP proteins eluted around 300 mM KCl.  
2.3.4 Normalization 
Protein concentration of PfTLP preparations were estimated by SDS PAGE and Coomassie 
staining using known amounts of BSA for comparison. Different preparations of 6:His tagged 
PfTLP protein were normalized using SDS PAGE and Coomassie staining and immunoblotting 
using anti-6His primary antibody (see section 2.3.6). Bovine serum albumin (BSA) (New 
England BioLabs®) was added to all protein preparations to a final concentration of 100 ng/μl. 
Final protein preparations were aliquoted, snap-frozen in liquid nitrogen and stored at -80 ⁰C. 
2.3.5 SDS-PAGE analysis 
Samples were mixed with 5x SDS-loading buffer (250 mM Tris-HCl pH 6.8, 10 % (w/v) SDS,  
30 % glycerol, 0.02 % (v/v) bromophenol blue) and denatured by heating at 85 ⁰C for 5 min. 
Samples were electrophoresed at constant 35 mA using 5% acrylamide (37:1) stacking gel, 
and 12 % acrylamide (37:1) resolving gel (Sigma-Aldrich®) using a mini-PROTEAN® system 
(Bio-Rad). Proteins were visualized using Bio-Safe G-25 Coomassie stain (Bio-Rad), or 
ProteoSilverTM Silver Stain Kit (Sigma-Aldrich®), following the manufacturer’s instructions. 
2.3.6 Immunoblotting  
After SDS-PAGE, proteins were transferred to Millipore® Immobilon  PVDF membrane using a 
Mini Trans-Blot® Electrophoretic Transfer Cell (Bio-Rad) at 100 V for 1 h at 4 °C. The 
membrane was washed three times for 5 min in TBST buffer (150 mM NaCl, 10 mM Tris pH 8,  
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0.05 % Tween 20), and once with water for another 5 min. After staining with Gold Solution 
(Sigma-Aldrich® 50755) for 1 to 3 h, the membrane was washed three times for 5 min in TBST, 
and blocked with 5 % (w/v) skim milk in TBST for 30 min. To detect recombinant 6His:tagged 
PfTLP proteins, the blocked membrane was incubated overnight at 4 ⁰C with anti-His probe 
rabbit polyclonal IgG (Santa Cruz Biotechnology, SC-803,) or anti-PfTLP rabbit anti-serum 
(Oelgeschläger lab; Bing, 2014; Milton, 2017; Talvik, 2016)) in  in TBST containing 5 % (w/v) 
skim milk, at a 1:3000 dilution. The membrane was washed three times for 5 min in TBST, and 
then incubated with secondary anti-rabbit IgG-peroxidase conjugate (Sigma-Aldrich®, A0545) 
in TBST, at a 1:3000 ratio, for 30 min at room temperature. Detection was carried out using 
WesternBrightTM Sirius (Advansta) kit following manufacturer’s instructions.  
2.4 DNA-binding Assays  
2.4.1 DNA Probes  
A 288 bp promoter region of the 130 kDa merozoite surface protein glycophorin-binding 
protein (GBP-130) (Hessler, 2014; Perkins, 1984) was used in DNA-binding experiments. The 
promoter sequence of GBP-130 was described previously (Lanzer et al., 1992a, 1992b; 
Ruvalcaba-Salazar et al., 2005). For ITA assays, a 5’biotinylated 422bp GBP-130 probe 
containing the 288 bp promoter region downstream of five GAL4 binding sites (Oelgeschläger 
et al., 1998) was used to increase the distance of the GBP-130 promoter region from the 
5’biotin-streptavidin link used to immobilize the DNA probe on magnetic beads. 288bp and 
422bp GBP-130 promoter probes were generated by PCR using plasmid pTHG5GBP-130 
(Hessler, 2014).  PCR amplification was carried out with 5’biotinylated forward and reverse 
primers to generate the 288bp GBP-130 EMSA probe and with a 5’biotinylated forward and 
an unmodified reverse primer to generate the 422bp GBP-130 ITA probe using the KAPA Taq 
PCR Kit (KAPA Biosystems) following the manufacturer’s instructions. Shorter 30-40 bp DNA 
probes used in EMSA assays were generated by annealing complementary DNA strands at 
1µM in TE buffer containing 100 mM NaCl, with 5min incubation at 95˚C followed by slow 
cooling to RT over 30 min. These included a 30 bp GBP-130 region as well as a 40 bp 
adenovirus 2 major late promoter (Ad2ML) probe with the typical TATA-box element (see 
Supplementary Table 2 for sequence details).   
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2.4.2 Immobilized Template Assays (ITAs) 
In ITAs proteins are incubated with biotinylated DNA probes that are immobilized on 
magnetic streptavidin beads. The unbound proteins are washed away and the bound proteins 
eluted (Johnson et al., 2004) and analysed with immunoblotting.  
2.4.2.1 Immobilization of probes  
10 µg of single biotinylated DNA template was immobilized on 1 mg Dynabeads® M-280 
Streptavidin (Invitrogen) according to the manufacturer’s instruction and immobilised DNA 
beads were stored in 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 1 M NaCl, 100ng/µL BSA. To confirm 
the amount of immobilized DNA, DNA was isolated from magnetic beads by phenol extraction 
and ethanol precipitation, followed by agarose gel electrophoresis and comparison with 
known amounts of free DNA probe. 
2.4.2.2 Binding reaction 
Standard ITA binding reactions contained 1 pmol of immobilized DNA probe, or the equivalent 
amount of magnetic beads without DNA  as control in a total volume of 40 µL. Prior to protein 
binding, beads were equilibrated with a 2:3 (v/v) ratio of template mix (20 mM HEPES, 5 mM 
DTT, 5 mM MgCl2, 0.1 % NP-40) and BC-100 buffer. For protein binding, a reaction mix of 16μl 
template mix and 24 μl protein in BC-100 buffer was added to the beads and incubated for 
45 minutes at 30 ⁰C using an Eppendorf shaker/incubator. After protein binding, the magnetic 
beads were precipitated in a magnetic tube rack, and the unbound fraction was then 
removed. The beads were washed in 2:3 (v/v) template mix and BC-100 buffer and transferred 
to a fresh tube, and the supernatant removed. Finally, beads were eluted in 1x SDS loading 
buffer. The eluates were heated at 80 ⁰C for two minutes and the supernatant analysed by 
SDS PAGE and immunoblotting. 
2.4.3 Electrophoretic Mobility Shift Assays (EMSAs)  
In EMSAs biotinylated DNA probes were incubated with proteins and free DNA probe 
separated from protein/DNA complexes using native agarose gel electrophoresis (Zerby and 
Lieberman, 1997). Binding reactions were made up from 4 µl template mix (20 mM HEPES, 
5 mM DTT, 5 mM Mg2Cl, 100 ng/μl BSA, 0.5 % NP-40) supplemented with  5 fmol of 
biotinylated DNA probe and poly(dG-dC) competitor (as indicated) and 6 µl protein mix in  
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BC-100 buffer. The reaction was incubated at 30⁰C for 45 min.  EMSA loading buffer (2.5% 
(w/v) ficol 400) was added to each reaction, samples were loaded onto 1.4% (w/v) Mg2+ 
agarose gels in 40 mM Tris, 40 mM boric acid, 5 mM magnesium acetate and resolved for 
 ~3 h at 100 V in 40 mM Tris, 40 mM boric acid, and 2 mM magnesium acetate at 4 ⁰C. 
Alternatively, EMSAs were resolved in native agarose gels lacking magnesium acetate in the 
gel and running buffer and electrophoresed for 30 min to 1 h at 100 V at 4 °C.  Following 
electrophoresis, the DNA probes and DNA/protein complexes were transferred to a 
Millipore® Immobilon-NY+ nylon membrane at room temperature (RT) for 90 min through 
horizontal vacuum transfer, using a modified southern/northern blot apparatus connected to 
a 240 mbar diaphragm pump (DA7C Charles Austen Pumps). Directly after the transfer the 
DNA was cross-linked using a commercial UV-cross linker, using four pulses of 120 mJ/cm2. 
Detection of biotinlylated DNA was carried out using the Chemiluminescent Nucleic Acid 
Detection Module (Thermo-Scientific®), following manufacturer’s instructions.  
2.5 Generation PfTLP low complexity regions fused to 
fluorescent protein 
2.5.1 Generation of Fusion Constructs  
Gene constructs for fluorescently tagged proteins were generated by PCR-driven overlap 
extension (Heckman and Pease, 2007) using primer sequences listed in supplementary table 
1. The gene for green fluorescent protein (GFP) was cloned from a vector based on the pEGFP 
(Clontech) vector, kindly donated by Shakiera Sattar (University of Cape Town, Department 
of Molecular and Cell Biology). The ORFs for yellow and cyan fluorescent proteins (YFP, CFP) 
were cloned from the pEarlyGate 101 and 102  vectors (Earley et al., 2006) respectively. These 
vectors were kindly donated by Dr Laura Roden (University of Cape Town, Department of 
Molecular and Cell Biology). ORFs for fusion proteins were inserted in pET11d-6His (Hoffmann 
and Roeder, 1991) using NdeI and BamHI sites (see Supplementary Fig. 1-3 for vector maps). 
Vector and insert sequences were verified by sequencing before being used for protein 
expression. A schematic of the vectors generated in this work are shown in (Fig. 28).  
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2.5.2  Expression and Purification of Fusion Proteins  
6His-GFP-PfTLP-LCR1, 6His-YFP-PfTLP-LCR2, and 6His-CFP-PfTLP-LCR2 were expressed in E.coli 
BL21-CodonPlus(DE3)-RIL as described in section 2.2 (Materials and Methods), except that 
protein expression was induced  by addition of 500 µM β-D-1-thiogalactopyranoside (IPGT) 
when cultures reached an OD600 of 0.5. Induced cultures were then further incubated for 3 h 
at 37 ⁰C with shaking before cells were harvested by centrifugation at ~3000 xg for 10 min.  
6His-tagged LCR1 and LCR2 fused to fluorescent protein were purified by metal-affinity 
chromatography as described in section 2.3 (Materials and Methods). Metal-affinity eluates 
were collected in LoBind (Protein) Eppendorf® tubes, snap-frozen in liquid nitrogen and 
stored at -80 ⁰C. 
2.6  Phase Separation Assays  
Glass chambers (Fig. 3) for examining phase separation of fluorescent fusion proteins were 
prepared based on a previously published procedure (Alberti et al., 2018). Briefly, glass slides 
and coverslips were silanized using Sigmacote® (Sigma-Aldrich) following manufacturer’s 
instructions. The silanized glass slides were rinsed in water, and two strips of double-sided 
tape placed lengthwise on both sides of the slide (Fig. 3). The assembled slide stage was rinsed 
with wash buffer (25 mM HEPES pH 7.4, 150 mM KCl, 1 mM DTT) before use.  
Phase separation reactions were assembled by mixing  one volume protein mix in BC-100 
buffer with one volume separation buffer (50 mM HEPES pH 7.4, 200 mM KCl, 1 mM DTT,  
40-50% PEG 20 000). The reactions were pipetted onto the assembled slide stage, and the 
coverslip added (Fig. 3). Reactions were visualized with a Nikon Ti-E inverted fluorescence 
microscope using appropriate filters for the emission of yellow fluorescent protein (YFP;  
520 – 550 nm) and cyan fluorescent protein (CFP; 460 – 500 nm). Images were rendered using 
Nikon NIS-Elements AR software. 
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Figure 3: Schematic of the modified glass chamber used to visualize phase separation reactions 
by fluorescent microscopy.   
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Chapter 3 
Results 
31. Bioinformatics Analysis of PfTLP  
Bioinformatics analysis was performed on the PfTLP amino acid sequence (See 
Supplementary Fig. 5 for full sequence) in order to investigate evolutionary conservation 
within the TBP family of proteins, as well as to gain insight into the structural and functional 
characteristics of PfTLP.   
TBP proteins consist of five classes; TBPs, and TBP-related factors (TRFs) 1-4, which expanded 
due to TBP gene duplication events  (Akhtar and Veenstra, 2011). TRF1 was originally 
discovered in Drosophila, and is an insect-specific TLP. TRF3 is only found in vertebrates, and 
is the TRF most closely related to TBP with 95 % amino acid identity to the TBP core domain. 
The human parasite Trypanosoma brucei has a single TBP-family protein, identified as TRF4. 
TRF2s are found in metazoans, and share roughly 60% homology with TBP. It is hypothesized 
that TLP/TRFs evolved to function in specific gene regulation programs, where they interact 
with core promoter elements and transcription factors different to that of TBP (Akhtar and 
Veenstra, 2011; Duttke et al., 2014; Thomas and Chiang, 2006; Wang et al., 2007).  
Phylogenetic tree analysis was used to evaluate the evolutionary relationship of PfTLP with 
different TBP-family proteins. Sequences were selected from model eukaryotic species, as 
well as some characterized archaebacteria.  As seen in Fig. 4, TBP-family proteins group 
roughly into thee clusters, a TBP/TRF3 cluster, a TRF2 cluster, and TRF1. PfTLP groups with 
the TRF2 type proteins (Fig. 4), consistent with a previous analysis (Bing, 2014; Milton, 2017).  
The result indicated that PfTLP might be a TRF2 type TLP.  
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Further analysis was done to see if the characteristic TBP-core domain structure was likely to 
be conserved in PfTLP. This analysis was achieved through the web-based program Phyre 2.0 
(Kelley et al., 2015), which predicts a three dimensional protein model by combining multiple 
sequence alignments with secondary structure predictions into a query hidden Markov 
model. The query is then scanned against proteins with solved structures, and the top scoring 
secondary structure alignment is used to construct a crude backbone, which is then 
transformed into a three dimensional model after loop and side chain rendering. As seen in 
Fig. 5, PfTLP is predicted to possess a typical saddle-shape TBP core domain consisting of eight 
β-strands and four α-helices.  Of note are two loop structures extending out of the core 
domain between β-strands S3 and S4, and S3’ and S4’, respectively. These regions were 
previously identified as low-complexity regions 1 and 2 (LCR1/2), and are predicted to be 
intrinsically disordered (discussed further in Results section 3.4; Bing, 2014; Milton, 2017).  
Figure 4: Phylogenetic tree analysis of TBP family proteins. A maximum-likelihood phylogenetic 
tree was rendered using Phylogony.fr (Dereeper et al., 2008), based on multiple sequence 
alignment results generated by MUSCLE (Edgar, 2004). Bootstrap test (100 replications) was 
performed.  Brackets are used to indicate the groups of TBP family proteins.  
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Figure 5: Predicted three dimensional structure model of PfTLP. Ribbon model of the PfTLP three-
dimensional structure. The conserved saddle-shaped TBP core domain structure is shown in blue, 
low complexity regions 1 and 2 are show in red and magenta, respectively. Evolutionary conserved 
phenylalanine residues F60 and F283, shown to insert into the DNA during TBP binding to the 
TATA box, are shown in green and supporting phenylalanine residues, F209 and F333, are shown 
in yellow. Model generated using UCSF Chimera 1.13 (Pettersen et al. 2004) based on Phyre 2.0 
analysis (Kelley et al., 2015). 
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Furthermore, the model shows that the phenylalanine residues, required for stable TATA-box 
binding by TBP, are conserved in PfTLP, in contrast to previously characterized TRF2-type TLPs 
(Duttke et al., 2014).  
A pair-wise sequence alignment was performed between PfTLP core domain and the most 
closely related solved structure of Saccharomyces cerevisiae TBP (ScTBP) (Fig. 6A). This 
analysis shows that the PfTLP core domain has a low sequence homology with ScTBP, with 
only 24 % identity and 49 % similarity. The highest degree of conservation between PfTLP and 
ScTBP was observed in the critical TBP secondary structures (Fig. 6A), outlined in the 
schematic shown in Fig. 6B.  
Collectively, this analysis suggests that PfTLP is likely to adopt the same three dimensional 
saddle-shaped DNA-binding core domain structure as prototypical eukaryotic TBPs (ScTBP), 
despite having a low sequence homology.  
In order to further examine the conservation of the phenylalanine residues important for TBP 
TATA box binding in PfTLP, a multiple sequence alignment was carried out with the sequences 
of the most closely related structures from the Phyre 2.0 (Kelley et al., 2015) analysis. As 
shown in Fig. 7, this analysis revealed a high degree of sequence similarity surrounding the 
conserved phenylalanine residues between PfTLP and eukaryotic (Saccharomyces cerevisiae, 
Sc; Encephalitozoon cuniculi, Ec) and archaeabacterial (Pyrococcus woesei, Pw, 
Methanococcus jannaschi, Mji) TBPs. This observation further supports the notion that the 
conserved phenylalanine residues might be important for PfTLP DNA-binding activity. The role 
of these phenylalanine residues in PfTLP DNA binding is further examined in Results  
section 3.3.  
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A 
B 
Figure 6: Predicted secondary structure architecture of PfTLP. A) Pairwise alignment of PfTLP 
core domain sequence with the core domain of Saccharomyces cerevisiae TBP (ScTBP). Alignment 
generated with Clustal Omega (Sievers et al., 2014). Identical amino acid residues are highlighted 
in black and marked with an asterisk (*),  highly similar amino acids (PAM 250 matrix score > 0.5) 
are highlighted in grey and marked with a colon (:), and weakly similar residues (PAM 250 matrix 
score < 0.5) are marked with a period (.). Conserved phenylalanine residues required for TBP 
binding to the TATA box are highlighted in red. Annotation of (H) α-helices and (S) β-sheets is 
based on the solved ScTBP structure (Chasman et al., 1993). B) Schematic of the PfTLP secondary 
structure based on the quasi symmetrical TBP core domain. (H) α-helices are shown as shaded 
boxes and (S) β-sheets as light blue arrows, with the identity of the flanking amino acid residues 
indicated. The location of the low-complexity regions (LCRs) are indicated in red. LCR1 spans the 
region from V70 to L203, and LCR2 from D296 to I329.  
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Figure 7: Multiple sequence alignments of the regions flanking the evolutionary conserved 
phenylalanine residues in PfTLP and in eukaryotic and archaebacterial TBPs. Identical amino acid 
residues are highlighted in black and marked with an asterisk (*), highly similar amino acids (PAM 
250 matrix score > 0.5) are highlighted in grey and marked with a colon (:), and weakly similar 
residues (PAM 250 matrix score < 0.5) are marked with a period (.). Conserved phenylalanine 
residues required for TBP binding to the TATA box are highlighted in red. Pf = Plasmodium 
falciparum, Pw = Pyrococcus woesei, Sc = Saccharomyces cerevisiae, Ec = Encephalitozoon cuniculi, 
and Mj = Methanococcus jannaschii. Alignments was carried out using Clustal Omega (Sievers et 
al., 2014).  
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3.2 Expression and Purification of PfTLP 
Expressing and purifying recombinant P. falciparum proteins comes with many caveats and 
limitations. The AT-rich genome of P. falciparum is one of the biggest obstacles in protein 
production. The AT-bias in the genome means that P. falciparum proteins not only use rare 
AT-rich codons, but it also leads to a major bias in genome wide amino acid usage (Yadav and 
Swati, 2012). This difference in amino acid usage places the bacterial host system under 
severe strain, leading to toxicity. Additionally, the rare codons can also lead to stalling of the 
translation machinery, causing truncated products (Birkholtz et al., 2008).  Another major 
issue with expressing P. falciparum proteins is the presence of low-complexity regions 
 (Fig. 6).  Proteins containing LCRs are often insoluble and aggregation prone, and therefore 
are often concentrated in inclusion bodies (Alberti et al., 2018; Birkholtz et al., 2008; Vedadi 
et al., 2007). Additionally, these proteins tend to be “sticky” and are retained on resins and 
certain surfaces. Special care must be taken to increase the solubility of these proteins, and 
this involves using low-binding reaction tubes and taking particular caution when changing 
salt concentrations.  
A his-tagged and codon optimized expression vector, as well as an initial protocol for 
expression and purification for PfTLP was previously established in the laboratory (Bing, 
2014). Briefly, a bacterial culture of transformed E.coli BL21- CodonPlus(DE3)-RIL was 
incubated at 37 °C until the culture reached an absorbance (0D600) of 0.5. The cells were then 
cold-shocked to 25 °C, and expression induced through the addition of isopropyl  
β-D-1-thiogalactopyranoside (IPTG). After a further 3h incubation at 25 °C, the cells were lysed 
through sonication and the soluble bacterial extract collected as cleared lysate. Finally 
6His:tagged recombinant PfTLP (6His:PfTLP) was purified from the soluble bacterial lysate 
through metal affinity chromatography (see Materials and Methods chapter 2).  
Fig. 8 shows an SDS-PAGE analysis of samples obtained during the different steps in of the 
6His:PfTLP bacterial expression and purification. There was no visible band in the whole cell 
lysate after induction, which indicates very low levels of expression.  Elution fractions 
contained very small amounts of a protein of the predicted molecular weight of 6His:PfTLP. 
The estimated yield was only 6 µg soluble 6His:PfTLP/l culture.  
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SDS PAGE analysis revealed that a significant proportion of 6His:PfTLP remained on the resin 
after elution, suggesting that PfTLP aggregated on the resin during the purification process, 
resulting in poor yield. The previously established purification protocol involved a rapid buffer 
exchange from the lysis buffer, of 500 mM NaCl, to the elution buffer, of 100 mM KCl. This 
rapid change in salt concentration may have caused the aggregation of 6His:PfTLP. To test this 
hypothesis and to improve 6His:PfTLP yield, the salt concentration was gradually adjusted 
through a step-wise equilibration process, which involved sequential washes with decreasing 
salt concentrations (500 mM NaCl, 400 mM NaCl, etc.). As shown in Fig. 9, in the purification 
Figure 8: SDS PAGE analysis of the initial 6His:PfTLP purification. Equivalent amounts of bacterial 
whole cell lysates before (B, lane 2), after induction with IPTG (A, lane 3), and equivalent amounts 
of metal affinity chromatography input (clear lysate, C, lane 4) and flow through (F, lane 5) and 
identical volumes of wash (W, lane 6) and elution fractions (lanes 7-8) were analyzed by 12% SDS-
PAGE and visualized by Coomassie staining.  60 ng, 120 ng, 250 ng and 500 ng bovine serum 
albumin (BSA) protein standard was loaded for comparison (lanes 11-14). The position of the 
protein band corresponding to the expected size of 6His:PfTLP (calculated molecular mass: 44.3 
kDa) is indicated by a solid triangle. M, molecular weight standard (lanes 1,15).  
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using a step-wise adjustment of the salt concentration, elution fractions contained increased 
amounts of a protein with the expected size of 6His:PfTLP (Fig. 9, lanes 6-8). Based on this the 
overall yield was estimated to be 18 µg of soluble 6His:PfTLP/l culture. Thus gradually 
changing the salt concentration on the metal affinity column prevented some aggregation 
and increased overall protein yield.  
Some minor contaminant bands could be seen in addition to 6His:PfTLP in the metal-affinity 
chromatography eluates (Fig. 9, lanes 6-8). Therefore, 6His:PfTLP was further purified using 
ion-exchange chromatography. 6His:PfTLP has an estimated pI of 9.28, and therefore a net 
Figure 9: SDS PAGE analysis of improved 6His:PfTLP purification protocol, using step-wise salt 
adjustment during metal affinity chromatography. Equivalent amounts of bacterial whole cell 
lysate before induction (B, lane 2) and after induction with IPTG (A, lane 3), and equivalent 
amounts of metal affinity chromatography input (clear lysate, C, lane 4), and flow through (F, lane 
5) and identical volumes of the elution fractions (lanes 6-8) were analyzed by 12% SDS-PAGE and 
visualized by  Coomassie staining. 50 ng, 100 ng , and 200 ng of bovine serum albumin (BSA) 
protein standard was added for comparison (lanes 9-11). The position of the protein band 
corresponding to the expected size of 6His:PfTLP (calculated molecular mass: 44.3 kDa) is 
indicated by a solid triangle. M, molecular weight standard (lanes 1,12). 
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positive charge in our buffer systems, and could therefore be further purified using  
SP-Sepharose FF® cation exchange chromatography. As expected, 6His:PfTLP bound to the 
SP-Sepharose FF® cation exchange resin. The majority of the 6His:PfTLP eluted at around  
300 mM KCl, and some of the contaminant bands were removed (Fig. 11 B, lanes 5-7). The 
final yield after SP-Sepharose purification was roughly 7 µg soluble 6His:PfTLP/l culture.  
The complete expression and purification protocol is shown as a schematic in Fig. 10.  The 
same expression and purification protocol was followed to produce preparations of 
6His:PfTLP wild-type, and mutant proteins 6His:PfTLP -F283A, -F60A, and –F60&283A. Fig. 12 
shows an SDS-PAGE analysis of the purified 6His:PfTLP wild-type and mutant protein 
preparations.  
 
Figure 10: Purification of bacterially expressed recombinant  6His:PfTLP. After binding to the Co2+ 
metal affinity column, salt is adjusted in a step-wise manner from 500 mM NaCl to 100 mM KCl 
(see Methods and Materials chapter 2). The metal affinity eluates are loaded onto a SP-Sepharose 
FF® cation exchange chromatography column and eluted with a linear gradient from 100 mM to 
500 mM KCl. Majority of the 6His:PfTLP elutes at a concentration of ~300 mM KCl.  
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Figure 11: SDS PAGE analysis of SP-Sepharose FF® cation exchange chromatography eluate 
fractions. Identical volumes of elution fractions (lanes 2-10) were analysed by 12% SDS-PAGE and 
visualized by Coomassie staining.  50 ng, 100 ng, and 200 ng bovine serum albumin (BSA) protein 
standard was loaded for comparison (lanes 11-13). The position of the protein band 
corresponding to the expected size of 6His:PfTLP (calculated molecular mass: 44.3 kDa) is 
indicated by a solid triangle. M, molecular weight standard (lanes 1,15). 
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Figure 12: SDS PAGE analysis of the final 6His:PfTLP wild-type and mutant protein preparations. 
Identical volumes of 6His:PfTLP wild-type  and F-to-A mutants F60A, F283A, and double mutant 
F60&283A (lanes 2-5) were analyzed by 12% SDS-PAGE and visualized by  Coomassie stained. Note 
that 100 ng/µl BSA was added to the final SP-Sepharose FF® purified protein preparations. The 
position of the protein band corresponding to the expected size of 6His:PfTLP (calculated 
molecular mass: 44.3 kDa) is indicated by a solid triangle. M, molecular weight standard (lane 1). 
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3.3 Characterization of PfTLP DNA Binding Activity   
PfTLP was previously shown to have DNA-binding activity (Bing, 2014; Milton, 2017). This 
study aimed to further characterize PfTLP DNA-binding activity and determine the roles of the 
evolutionary conserved phenylalanine residues.  
The DNA-binding activity of wild-type PfTLP was first investigated using an immobilized 
template assay (ITA). Briefly, biotinylated DNA probes are immobilized on streptavidin-coated 
magnetic beads and proteins are incubated with the immobilized DNA probes. The unbound 
proteins are washed away, and bound proteins are detected by immunoblot analysis. As a 
control, magnetic beads without DNA are used to ensure the proteins are binding the DNA 
and not the beads (Johnson et al., 2004).  
As shown in Fig. 13 purified recombinantly expressed 6His:PfTLP bound quantitatively to a 
immobilized 422 bp P. falciparum glycophorin binding protein (GBP-130) promoter DNA 
probe, whereas binding to the magnetic beads only was undetectable (Fig.13 , compare lanes 
2, 4, 6 and 3, 5 and 7). This result showed that the recombinant 6His:PfTLP produced in this 
study has DNA binding activity.  
 
Figure 13: Binding of PfTLP wild-type to an immobilized P. falciparum glycophorin binding 
protein (GBP-130) promoter region. 140 ng of immobilized 422 bp GBP-130 or equivalent amount 
of magnetic beads only (lanes 2-7) were incubated with indicated amounts of 6His:PfTLP in 40 µl 
binding reactions. Unbound proteins were washed away with binding buffer and the bound 
proteins eluted with SDS loading buffer. 50 % of eluates (lanes 2-7) and 20 ng of 6His:PfTLP input 
(lane 1) were analysed using immunoblot and detected with anti-6His (rabbit) primary antibody 
and anti-rabbit IgG-peroxidase secondary antibody. Protein bands were visualized on X-ray film 
using chemiluminescence.  
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The DNA-binding activity of wild-type 6His:PfTLP was further investigated using the 
electrophoretic mobility shift assay (EMSA). In this assay the protein is incubated with labelled 
DNA probes and then free DNA is separated from protein/DNA complexes in native gel 
electrophoresis (Hellman and Fried, 2007). EMSAs are thought to be more stringent because 
the complexes must be stable enough to be resolved in the gel matrix during electrophoresis. 
Previous work in the laboratory has shown that 6His:PfTLP tends to be retained in the well in 
EMSAs using native PAGE. This issue could be resolved by using agarose gel electrophoresis 
with Mg2+ present during electrophoresis (Bing, 2014; Milton, 2017; Zerby and Lieberman, 
1997). Therefore, native agarose EMSAs were used in this study.  
The EMSAs were initially performed using a 1.4% agarose gel with Mg2+ present in the gel and 
running buffer. Under these conditions 6His:PfTLP DNA binding was clearly detectable, 
(Fig. 14A), consistent with previous observations  (Bing, 2014; Milton, 2017, ).  However, the 
PfTLP complexes showed only slightly reduced mobility and were not well separated from the 
free probe (Fig. 14A ,Bing, 2014; Milton, 2017; Talvik, 2016,). The presence of Mg2+ affects the 
EMSA assay conditions in several ways. Firstly, Mg2+ is required for stable complex formation 
of many DNA-binding proteins (Moll et al., 2002). Secondly, during electrophoresis, Mg2+ 
present in gel and running buffer migrate in the opposite direction as free DNA and 
DNA/protein complexes and neutralize the negative change on the DNA backbone, thereby 
slowing the migration of the free probe and DNA-protein complexes in the electric field. For 
this reason, agarose EMSA’s were carried out in the absence of Mg2+ to improve the 
separation between the free DNA probe and DNA/protein complexes.  
Fig. 14 panels A and B illustrates the effects of Mg2+ during electrophoresis on the mobility of 
free DNA probe and 6His:PfTLP/DNA complexes in native agarose EMSA. In the absence of 
Mg2+, the complexes were better resolved (compare Fig. 14 A and B, lanes 2 and 3). 
Additionally, when Mg2+ was omitted during electrophoresis, a larger proportion of the DNA 
probe was bound by 6His:PfTLP (Fig. 14, compare panel A with panels B and C). This indicates 
that the presence of Mg2+ during electrophoresis reduced the stability of 6His:PfTLP/DNA 
complexes.  In the absence of Mg2+ ions during electrophoresis, PfTLP showed similar binding 
activity to a 288 bp GBP-130 promoter region, and a 40 bp region of the adenovirus 2 major 
late promoter (Ad2ML) (See Supplementary Table 2 for sequences), containing a prototypical 
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TATA-box element (Fig. 14 B and C).  However, in the case of the Ad2ML promoter two distinct 
complexes were observed, a complex with greatly reduced mobility and a second complex 
with only slightly reduced mobility when compared to the free DNA probe (Fig. 14 C, lanes 2-
3). Together, these results suggest that PfTLP can bind DNA probes of different length and 
sequence, and that the presence of Mg2+ during electrophoresis destabilizes 6His:PfTLP/DNA 
complexes.  
Protein/DNA interactions are largely electrostatic and therefore generally sensitive to 
increased salt concentrations. It has been shown that the DNA-binding activity of eukaryotic 
TBP is decreased at salt concentrations above 60 mM and temperatures above 30 °C 
(Nakajima, 1988; Petri, 1995).  Because the ideal binding conditions for 6His:PfTLP DNA 
binding is not known, the effect of salt (KCl) concentration and temperature on DNA-binding 
was investigated. As seen in Fig. 15 DNA-binding of PfTLP was not significantly affected by KCl 
concentrations up to 460 mM, and incubation temperatures up to 42 °C. However, at 60 °C 
no binding was detectable, presumably because PfTLP denatures at this temperature. This 
Figure 14: The effect of Mg2+ in 6His:PfTLP agarose EMSAs. 10 µl binding reactions containing  
5 fmol 288 bp GBP-130 promoter region (A ,B) or 40 bp Ad2ML promoter probes (C) and indicated 
amounts of 6His:PfTLP were resolved in a 1.4 % agarose gel in the presence (+ Mg2+ ) or absence 
(- Mg2+) during electrophoresis. After electrophoresis, the biotinylated DNA was transferred to a 
nylon membrane and detected on X-ray film via chemiluminescence using a stabilized 
streptavidin-horseradish peroxidase conjugate. The positions of free DNA probe and 
6His:PfTLP/DNA complexes are indicated. A second Ad2ML complex with higher mobility is 
indicated in (C) with an asterisk. 
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shows that PfTLP is far less sensitive to salt when compared to typical eukaryotic TBPs that 
were previously characterized, and may also be less sensitive to temperature (Nakajima et al., 
1988; Petri et al., 1995)  Since no significant difference was seen in overall DNA-binding 
activity, previously established conditions for eukaryotic TBP DNA binding, with 60 mM KCl 
present in the binding reaction and incubation temperature of 30 °C, were used for further 
experiments.  
 
 
3.3.1 Role of Evolutionary Conserved Phenylalanine Residues in PfTLP DNA Binding  
In PfTLP, F60 and F283 are predicted to correspond to the two phenylalanine residues which 
insert into the TATA-box promoter element during DNA-binding by TBP (Fig. 6 and 7). To 
investigate their roles in PfTLP, mutations were introduced, whereby the phenylalanine 
Figure 15: The effect of salt concentration and temperature on the DNA-binding activity of 
6His:PfTLP. 10 µl reactions containing 5 fmol 288 bp GBP-130 probe and 30 ng PfTLP and were 
incubated for 45 min at 30 °C in the presence of indicated concentration of KCl (lanes 2-6) or at 
60 mM KCl at indicated incubation temperatures (lanes 8-13). Free probe and protein/DNA 
complexes were resolved in 1.4% agarose with MgCl2 added to the gel and running buffer. After 
electrophoresis the DNA was transferred to a nylon membrane and detected on X-ray film using 
chemiluminescence. Two different exposures of the same experiment are shown. The positions 
of the free probe and 6His:PfTLP/DNA complexes are indicated. 
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residues were substituted with an alanine residue. Expression constructs for single mutants 
6His:PfTLP-F60A, -F283A, and double mutant -F60&283A were previously generated in the 
laboratory ( Adebolajo, 2016). These mutant proteins were expressed and purified using the 
protocol established for wild-type 6His:PfTLP (Chapter 2.2, Fig. 10).   
Under standard ITA conditions, with 50 nM DNA, both the double, F60&283A, and single, 
F60A and F283A, mutant PfTLP proteins bound the immobilized 422 bp GBP-130 probe, with 
similar activity as the wild-type protein  (Fig. 13). This experimental condition did not yield 
any information about differences in binding affinity or stability in response to the F-to-A 
mutation. In order to create more stringent binding conditions the DNA concentration in the 
ITA was decreased to 10 nM and 2.5 nM. Indeed, as shown in Fig. 16, decreasing the amount 
of DNA in the ITA decreased the overall PfTLP DNA binding activity. Moreover, decreasing the 
DNA concentration also revealed differences in the binding activity of wild-type and mutant 
PfTLPs. The DNA binding of the mutant proteins carrying the F60A mutation was clearly 
diminished when compared to the wild-type PfTLP. In contrast, the binding of the F283A 
mutant is indistinguishable from the wild-type protein.  This suggested that the F60A 
mutation had a detrimental effect on PfTLP DNA-binding activity.  
The DNA binding of the wild-type and mutant PfTLP proteins was further investigated in EMSA 
experiments in the absence Mg2+ added during electrophoresis. As shown in Fig. 17, both the 
wild-type and the F283A mutant bound the 40 bp Ad2ML promoter with similar activity, 
whereas, the binding activity of the single, F60A,mutant and the double, F60&283A, mutant 
was clearly diminished.  This result is consistent with the ITA carried out at low DNA 
concentrations (Fig. 16), where the F60A mutation reduced PfTLP DNA binding activity.  
The effects of Mg2+, during EMSA electrophoresis, on the stability of the protein/DNA 
complexes formed by the F-to-A mutant proteins was further investigated. As seen in Fig. 18A, 
in an EMSA with Mg2+ added during electrophoresis, the binding of PfTLP wild-type and F283A 
to the 288 bp GBP-130 promoter was clearly detectable, whereas the binding of the single, 
F60A, and double, F60&283A, mutants was undetectable. This further corroborates the 
observation that the F60A mutation greatly diminishes DNA binding activity.  
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Figure 17: Effects of F-to-A mutations on PfTLP DNA binding. 10 µl EMSA binding reactions 
containing 5 fmol of 40 bp Ad2ML promoter with 15 ng of 6His:PfTLP wild-type (lane 2), F60A (lane 
3), F283A (lane 4), and F60&283A (lane 5) were resolved in a 1.4 % agarose gel in the absence of 
Mg2+. After electrophoresis, DNA was transferred to a nylon membrane and detected via 
chemiluminescence on X-ray film. The positions of free DNA probe is indicated.  
Figure 16: The effect of decreasing amounts of DNA on DNA binding of recombinant PfTLP  
wild-type and mutant proteins in immobilized template assay (ITA). 25 ng of recombinant 
6:His:PfTLP wild-type or mutant proteins carrying the F60A, F283A, and F60&283A substitution 
were incubated with indicated concentrations of immobilized 422 bp GBP-130 in 40 µl binding 
reactions. Unbound proteins were washed away with binding buffer and the bound proteins 
eluted with SDS loading buffer. 50 % of eluates (lanes 1-4) were analysed by immunoblotting and 
detected with rabbit anti-6His primary antibody and anti-rabbit IgG-peroxidase secondary 
antibody. Protein bands were visualized on X-ray film using chemiluminescence. 
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In contrast, in EMSAs without Mg2+ present during electrophoresis, the binding activity of all 
mutant PfTLP proteins to the 288 bp GBP-130 promoter were diminished when compared to 
that of wild-type PfTLP (Fig. 18B, compare lanes 2, 5, 8, and 11). Furthermore, under these 
conditions, F60A and F283A point mutations diminished PfTLP binding activity to a similar 
extent and in a cumulative fashion, with the binding activity of the F60&283A double mutant 
further reduced compared to the F60A and F283A single mutant PfTLP proteins.  This 
observation suggests that both F60 and F283 are important for PfTLP DNA binding. However 
the observation that the presence of Mg2+ during electrophoresis destabilized the PfTLP/DNA 
complex for the mutants carrying the F60A mutation suggests that, while both F60 and F283 
contribute to PfTLP DNA binding activity, the stability of the PfTLP/DNA complexes is critically 
dependent on F60, but not on F283.  
Interestingly, in EMSA experiments carried out in the absence of Mg2+ during electrophoresis, 
the mobility of the wild-type PfTLP/DNA complex appeared reduced when compared to that 
of the mutant PfTLP proteins (Fig. 18B). For this reason, an additional experiment was 
conducted to investigate the differential complex mobility by comparing the PfTLP/DNA 
complexes formed in the presence of saturating amounts of wild-type and mutant PfTLPs 
side-by-side.  The result of the experiment (Fig. 19) confirms that, in an EMSA without Mg2+ 
during electrophoresis, the wild-type PfTLP/DNA complex has a lower mobility when 
compared to the mobility of the single F60A and F283A, and double F60&283A mutants. This 
result might indicate different conformations of nucleoprotein complexes formed with wild-
type and mutant PfTLPs.  
A competition experiment was conducted to further investigate the contribution of the F283 
residue on the stability of the PfTLP/DNA complexes. Reactions containing saturating 
amounts of PfTLP wild-type and F283A, which results in the quantitative binding of the 288 bp 
GBP-130 promoter DNA probe, was challenged by a non-specific competitor DNA.  
Poly(dG-dC) was chosen as an ideal non-specific competitor, given the A/T-rich genome of 
P. falciparum. The experiment was conducted under more stringent conditions, with the 
addition of Mg2+ to the gel and running buffer.  As shown in Fig. 20, binding of both wild-type 
PfTLP and the single F283A mutant to the 288 bp GBP-130 promoter DNA probe decreased 
with increasing amounts of poly(dG-dC) competitor. However, the presence of 25ng  
poly(dG-dC) (~ 77 pmol nucleotides) did not significantly affect wild-type PfTLP DNA 
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complexes,  but  was enough to recover free probe in the presence of the PfTLP F283A mutant. 
(Fig. 20, compare lanes 1, 5 and 6). Considering that the standard binding reaction only 
contains 5 fmol of 288 bp GBP-130 probe (~2.9 pmol, 82.5% A/T), that means a ~27 fold excess 
of competitor DNA was required to compete for binding of the F283A mutant, whereas 
~54 fold excess was required to compete for the binding of the wild-type PfTLP. This result 
suggests that PfTLP has a preference for A/T rich DNA sequences, which is diminished by the 
F283A mutation.  
Together these results show that wild-type PfTLP has DNA-binding activity, and forms 
complexes with various DNA probes. PfTLP/DNA complexes are disrupted in an EMSA 
experiment when Mg2+ is present during electrophoresis. The DNA-binding activity of wild-
type PfTLP was shown not to be sensitive to high concentrations of salt, which may indicate 
that the binding is mostly mediated by hydrophobic interactions. The PfTLP/DNA complexes 
are also stable under higher temperatures, which differs from characterized eukaryotic TBPs. 
The F-to-A mutations in the evolutionary conserved phenylalanine residues revealed that the 
phenylalanine residues are not required for general DNA binding activity, but affect DNA 
complex stability, presumably at A/T-rich target sequences. Overall, the F60A mutation 
affected the stability of the PfTLP/DNA complexes to a much greater extent than the F283A 
mutation.  Of note, is that the DNA complexes formed with F-to-A mutant PfTLP proteins 
showed increased mobility in agarose EMSAs when compared to the wild-type PfTLP, this 
indicating that these mutations affect the overall conformations of the PfTLP/DNA complexes.  
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A      (+Mg2+) 
B       (-Mg2+) 
Figure 18: Effects of F-to-A mutations on PfTLP in agarose EMSAs in the presence and absence 
of Mg2+ during electrophoresis.  (A) 10 µl EMSA binding reactions containing 5 fmol of 288 bp 
GBP-130  promoter DNA probe and 30 ng of 6His:PfTLP wild-type (lane 2), and F60A (lane 3), 
F283A (lane 4) and F60&283A mutant variants (lane 5) were resolved in a 1.4% agarose gel with  
Mg2+ present during electrophoresis. (B) EMSA conditions identical to (A) were electrophoresed 
in 1.4 % agarose gel without Mg2+ present during electrophoresis. After electrophoresis, DNA was 
transferred to a nylon membrane and detected via chemiluminescence on X-ray film. The 
positions of free DNA and PfTLP/DNA complexes are indicated. 
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Figure 20: The effect of non-specific competitor DNA on DNA-binding of recombinant PfTLP 
wild-type and F283A.  10 µl EMSA binding reactions contained 5 fmol 288 bp GBP-130 promoter 
DNA probe and 60 ng of 6His:PfTLP wild-type (lanes 2-7) and F283A mutant (lanes 9-14) with 
indicated amounts of the competitor DNA poly(dG-dC). Binding reactions were resolved in a  
1.4% agarose gel in the presence Mg2+. After electrophoresis, DNA was transferred to a nylon 
membrane and detected via chemiluminescence on X-ray film. The positions of free DNA probe 
and 6His:PfTLP/DNA complexes are indicated.  
 
Figure 19: Differential mobility of DNA complexes formed with recombinant PfTLP wild-type 
and F-to-A mutant proteins. 10 µl EMSA binding reactions contained 5 fmol of 288 bp GBP-130 
promoter DNA probe and indicated amounts of 6His:PfTLP wild-type (lane 2), F60A (lane 3), F283A 
(lane 4), and F60&283A (lane 5). Protein/DNA complexes were resolved in a 1.4% agarose gel in 
the absence of Mg2+. After electrophoresis, DNA was transferred to a nylon membrane and 
detected via chemiluminescence on X-ray film. The position of free DNA probe is indicated.  
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3.4    Characterization of PfTLP Low Complexity Regions  
3.4.1 Bioinformatics  
Bioinformatics analysis revealed that PfTLP contains two low complexity regions, LCR1 and 2, 
which are located between β-strands S3 and S4, and S3’ and S4’ within the two  
intra-molecular repeats of the TBP core structure (Fig. 6B, Bing, 2014; Milton, 2017) .   
LCRs often coincide with intrinsically disordered regions (IDR). Several different programs and 
algorithms have been developed to identify and characterize low-complexity (LCR) and 
intrinsically disordered regions (IRDs). A powerful tool to predict disorder based on amino 
acid sequence is DisMeta (Huang et al., 2014). Dismeta is a meta-server that collates and 
curates the outputs from various disorder prediction programs.  The output from DisMeta is 
a consensus disorder prediction for every amino acid residue position, based on the 
predictions from eight different sequence-based disorder prediction programs.  The server 
also includes the SEG algorithm, the original low-complexity prediction program designed by 
Wootton and Federhen at the National Center for Biotechnology Information (NCBI) 
(Wootton and Federhen, 1993). As seen in Fig. 21, the output from DisMeta identified both 
LCR1 and LCR2 as regions with a high probability of disorder.  These regions were also 
categorized as low-complexity through the SEG algorithm (data not shown).  
Once identified as LCR/IDR, the sequence composition, bias, and patterning of the PfTLP LCRs 
was investigated. The relationship between protein sequence composition, propensity to 
form disordered regions, and phase separating behaviour was previously analysed by sorting 
the amino acid residues of a given sequence into set categories, specifically highlighting polar, 
hydrophobic, charged, and aromatic residues and comparing their ratios (Martin and Mittag, 
2018). For example, glycine is generally overrepresented in these IDRs and has been shown 
to play a role in the phase separating behaviour of many IDRs. The process of categorizing 
amino acid residues was applied to both PfTLP LCR1 and LCR2, in order to investigate the 
amino acid bias in these two regions. As seen in Fig. 22 both LCRs contain a large proportion 
of charged residues, as well as randomly distributed aromatic residues (Fig. 22).  Both PfTLP 
LCR1 and 2 are enriched in polar residues such as asparagine and serine residues (Fig. 22). In 
addition, PfTLP LCR1 contains repeating units of asparagine and serine residues in various 
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combinations (Fig. 22, A). Interestingly, glycine is underrepresented in both sequences  
(Fig. 22). An abundance of charged and aromatic residues was correlated earlier with a high 
propensity for phase separation (Martin & Mittag, 2018). The lack of glycine in PfTLP LCR1 
and LCR2 may be explained by the fact that the codon for glycine is GC-rich (GGN). Thus, in 
the context of the AT-rich P. falciparum genome, glycine may have been substituted with the 
AT-rich codon of asparagine (AAT, AAC).  
In order to establish whether the observed bias in amino acid use towards asparagine and 
serine residues was specific to PfTLP LCRs, or simply a result of the general AT rich codon bias 
in the P. falciparum genome, the amino acid use in the PfTLP LCRs was compared to that of 
the structured core domain of PfTLP and the entire P. falciparum proteome (Fig. 23, Yadav & 
Swati, 2012). As seen in Fig. 23, the P. falciparum proteome is enriched in asparagine (14%) 
and lysine (12%) residues compared to other amino acids. Both asparagine and lysine residues 
have AT-rich codons, and therefore this enrichment might be a result of the overall genome 
AT bias. The amino acid composition of PfTLP core domain roughly reflects that of the  
P. falciparum proteome, with a few exceptions. The core domain is slightly enriched in 
branched aliphatic amino acids, such as isoleucine (10.7%) and valine (6.8%), whereas  
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Figure 21: Disorder prediction profile of PfTLP. Output from DisMeta provides a disorder prediction 
for every amino acids residue (Huang et al., 2014), based on the scores from eight different 
sequence-based disorder prediction programs.  The standard threshold for a high probability of 
disorder is identified at 0.5 with a red line. The positions of PfTLP LCR1 and LCR2 are indicated.  
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Figure 22: Amino acid composition of PfTLP LCRs. The amino acid sequence of PfTLP LCR1 (A) and 
LCR2 (B), are shown with amino acid highlighted according to the colour key. Pie charts represent 
the percentage of each category present in the respective full length LCR sequence. Data 
generated with ProtoParam (Gasteiger et al., 2005). 
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negatively charged amino acids like aspartic and glutamic acid are underrepresented (2.4% 
and 3.4% respectively) (Fig. 23). In the DNA-binding domain of eukaryotic TBP branched 
hydrophobic amino acids contact base pairs inside the minor groove of the DNA. 
Furthermore, the DNA binding surface of TBP is also characterized by a  net positive surface 
charge in order to facilitate interaction with the negatively charged DNA backbone (Kim and 
Burley, 1994; Kim et al., 1993; Nikolov et al., 2002).  Thus, the observed enrichment in 
branched aliphatic amino acid residues and underrepresentation of negatively charged amino 
acid residues is consistent with the result of the Phyre2 analysis which predicts that PfTLP 
adopts a TBP-like structured core domain.  PfTLP LCR1 and LCR2 are both enriched for 
asparagine (23.3% and 25%), lysine (16.3% and 16.7%) and serine (11.6% and 11.1%) residues 
when compared to the PfTLP core domain and P. falciparum proteome. Interestingly LCR2 is 
also specifically enriched in aspartic acid (16.7%) (Fig. 23), and this contributes to the overall 
negative charge of LCR2.  Taken together, this analysis shows that the  amino acid content of 
PfTLP LCR1 and LCR2 is different to the PfTLP structured core domain and the entire  
P. falciparum proteome as LCR1 and LCR2 are specifically enriched in certain amino acid 
residues, and that this bias is not merely a result of the P. falciparum genome-wide codon 
bias.  
To address the question of whether these LCRs are a general feature of TLPs in Plasmodium, 
multiple sequence alignments were performed using putative TLP orthologues from various 
Plasmodium species, which were identified using a BLAST search. Multiple sequence 
alignment of putative PfTLP orthologues revealed the presence of LCRs in the same positions 
as PfTLP LCR1 and LCR2 (full alignment available in Supplementary Fig. 4). DisMeta analysis 
confirmed that the LCR regions in Plasmodium species PfTLP orthologues are also predicted 
to be highly disordered (Fig. 24). These observations suggests that the presence of two LCRs 
with a propensity to form disordered regions, located between β-strands S3/S4 and S3’/S4’ 
within the structured PfTLP core domain, is a general feature of Plasmodium TLPs.  
Next, the sequence conservation of the LCR sequences in the TLP orthologues from different 
Plasmodium species was investigated. LCR1 sequences could not be meaningfully aligned by 
multiple sequence alignment, suggesting that there is very low sequence conservation in the 
LCR1 sequences from different Plasmodium species (data not shown). An exception to this 
was the Laverania subgenus, which includes the closely related primate-specific P. falciparum, 
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P. reichenowi, and P. gaboni, that showed a high degree of sequence homology (Loy et al., 
2017). In contrast, there is a high level of conservation between the LCR2 sequences from 
various Plasmodium species, with a central (F/Y)AW motif conserved in all orthologues 
analysed (Fig. 25). As with LCR1, there is a higher degree of homology between LCR2s from 
the subgenus Laverania. (Fig. 25, Loy et al., 2017). Overall evolutionary conservation of 
sequence for Plasmodium TLP LCR1s could not be detected, but there is a high level of 
sequence conservation for the LCR2 regions from Plasmodium TLP orthologues. This might 
suggest that the LCR2 region serves a specific function that is conserved within Plasmodium. 
 Previous studies have shown that the tendency for intrinsic disorder and the ability to phase 
separate is not mediated by specific amino acid sequence, but rather by regions of a particular 
amino acid composition (Brangwynne, Tompa & Pappu, 2015; Martin & Mittag, 2018; 
Turoverov et al., 2019). Therefore, further analysis was done to compare the amino acid 
compositions of the LCR1 regions from the various Plasmodium orthologues. As shown in 
Fig. 26 these regions have considerable variation in the amino acid compositions between 
different species. This variation may be a consequence of the difference in GC content of the 
various Plasmodium genomes, which in turn may bias amino acid codon usage. To further 
illustrate the variation in amino acid distribution, the amino acid composition of the TLP LCR1 
regions from P. falciparum, with a genome GC content of 19% (Carlton et al., 2008), was 
compared to that of P. vivax, with a genome GC content of 57% (Carlton et al., 2008).  As seen 
in Fig. 27, PfTLP LCR1 is enriched in asparagine (23.3%), lysine (16.3%), serine (10.9%), 
isoleucine (10.1%), and aspartic acid (8.5%) residues. In contrast, PvTLP LCR1 is enriched in 
proline (9.9%), threonine (21.8%), glycine (15.8%), glutamic acid (16.8%), and glutamine 
(10.9%) residues. It is interesting to note that PfTLP LCR1 is specifically enriched in the 
phosphor acceptor serine, whereas PvTLP LCR1 is specifically enriched in the phosphor 
acceptor threonine. Similarly, the major charge carrying residue in PfTLP LCR1 is lysine, 
whereas in PvTLP LCR1 it is glutamic acid. Interestingly, glycine is overrepresented in PvTLP 
LCR1, which is a hallmark generally associated with LCRs with a high propensity to phase 
separate (Martin & Mittag, 2018). Together, these results indicate that there is little 
conservation in sequence or amino acid composition within the LCR1 regions of the various 
Plasmodium TLP orthologues. However, certain features, for example the enrichment of 
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potential phosphor acceptor residues, appear to be conserved. This may point to a potential 
role of phosphorylation in the regulation of PfTLP function through these regions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Amino acid usage in PfTLP and the P. falciparum proteome. Percentage amino acid 
residue use in PfTLP-LCR1 (blue) and -LCR2 (orange), PfTLP structured domain (green) and the 
entire P. falciparum proteome (yellow) are shown. Proteome data were adapted from (Yadav and 
Swati, 2012). PfTLP data generated with ProtoParam (Gasteiger et al., 2005). 
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Figure 24: Consensus disorder prediction for TLP orthologues from various Plasmodium species. 
The output from DisMeta (Huang et al., 2014) shows the consensus disorder prediction for every 
amino acid position, based on the scores from eight different sequence-based disorder prediction 
programs for every Plasmodium TLP orthologue sequence.  The standard threshold for disorder is 
identified at 0.5 with a red line. Two peaks of heightened disorder can be observed in all the 
Plasmodium TLPs corresponding to LCR1 and LCR2 in PfTLP.  
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Figure 25: Multiple sequence alignment and phylogenetic tree analysis of TLP2 regions in 
various Plasmodium species.  A) Multiple sequence alignment of the TLP LCR2 regions of various 
Plasmodium species. Alignment done with MUSCLE (Edgar, 2004) and visualized in UGENE 
(Okonechnikov et al., 2012). Light grey highlighting represents residues with a > 50% identity, 
medium grey residues with > 80% identity, and dark grey residues with 100% identity. 
 B) A maximum-likelihood phylogenetic tree of the TLPs from various Plasmodium species was 
rendered through UGENE (Okonechnikov et al., 2012), based on the multiple sequence alignment 
results, generated by MUSCLE (Edgar, 2004). Bootstrap test (100 replications) was performed.  
Brackets are used to indicate the various hosts of the different Plasmodium species, with the 
primate-specific subgenus of Laverania indicated. Pg = P. gaboni, Pr = P. reichenowi, 
 Pm = P.malariae, Po = P.ovale, Prel = P. relictum, Pv = P.vivax, Py = P. yoelii, Pca = P. chabaudi 
adami, and Pf = P. falciparum. 
A 
B 
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Figure 27: Percentage amino acid use in P. falciparum TLP-LCR1 (orange) compared to P. vivax 
TLP-LCR1 (green). Data generated with ProtoParam (Gasteiger et al., 2005). 
Figure 26: Percentage amino acid use in the LCR1 region of various Plasmodium TLP orthologue 
proteins. Data generated with ProtoParam (Gasteiger et al., 2005). 
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3.4.2 Generation of LCR fusion Proteins  
In order to investigate the potential of the PfTLP LCRs to drive liquid-liquid phase separation 
(LLPS), recombinant 6His tagged versions of LCRs fused to fluorescent protein were generated 
(Fig. 28A), bacterially expressed and purified from bacterial lysates by metal-affinity 
chromatography (Materials and Methods, Chapter 2.5). An SDS PAGE analysis of purified LCR 
fluorescent fusion proteins is shown in Fig. 28B.  
A 
B 
Figure 28: Recombinant bacterially expressed 6His:tagged PfTLP LCR-fluorescent fusion 
proteins.  (A) Schematic of the PfTLP LCR fusion proteins constructs. N-terminal 6His tagged green, 
yellow or cyan fluorescent protein (GFP, YFP, and CFP) was fused to the N- terminus of either 
PfTLP LCR1 or PfTLP LCR2.  (B) SDS PAGE analysis of purified recombinant 6His-tagged TLP LCRs 
fused to fluorescent proteins. 125 ng and 250 ng of purified recombinantly expressed 
 6His:YFP-PfTLP-LCR1 (lanes 2-3), 6His:CFP-PfTLP-LCR2 (lanes 4-5), and 6His:GFP-PfTLP-LCR2 
(lanes 6-7) were analysed by 12% SDS PAGE and visualized by Coomassie staining. The positions 
of selected molecular weight standards are indicated. The calculated molecular mass of LCR1 and 
LCR2 fusion proteins are 38 kDa and 33 kDa, respectively. M, molecular weight marker, YFP; yellow 
fluorescent protein, CFP; cyan fluorescent protein, GFP; green fluorescent protein. 
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3.4.3 Phase Separation Assays  
In order to test if PfTLP-LCR1 and -LCR2 are able to drive LLPS the YFP-PfTLP-LCR1 and  
CFP-PfTLP-LCR2 fusion proteins were used in phase separating assays, based on published 
methodology. Briefly, proteins are mixed into a phase separation buffer, which has a set pH, 
salt concentration, and percentage crowding agent such as polyethylene glycol (PEG) or 
dextran (Alberti et al., 2018; Wang et al., 2018).  The reactions are then examined on modified 
glass slides by fluorescent microscopy (see Materials and Methods, chapter 2.6). In the phase 
separation assays used in this study 14 µM protein was incubated with 7-25% PEG and  
150 mM KCl at a pH of 7.4. 
In the initial assays YFP-PfTLP-LCR1 or CFP-PfTLP-LCR2 were assayed separately. At a protein 
concentration of 14 µM protein, and in the presence of 7-15 % PEG no phase separation was 
observed, and both proteins stayed in solution. However, in the presence of 20-25 % PEG  
YFP-PfTLP-LCR1 formed spherical droplets with increased fluorescence, that were also visible 
in phase contrast or differential interference contrast (DIC) microscopy (Fig. 29, panel A). In 
contrast, LLPS droplet formation could not be observed with 14 µM CFP-PfTLP-LCR2 in the 
presence of 25% PEG, (Fig. 29, panel A), and the protein remained uniformly distributed in 
solution.  Thus PfTLP-LCR1, but not PfTLP-LCR2, is able to undergo LLPS under these 
conditions.  
Proteins able  to drive LLPS and the formation of membraneless organelles on their own are 
referred to as scaffold proteins, whereas proteins that are selectively recruited to these phase 
separated droplets are called client proteins (Bergeron-Sandoval and Michnick, 2018; Ditlev 
et al., 2018; Posey et al., 2018). The recruitment of these client proteins to phase separated 
droplets might be mediated through modular protein domains or LCRs (Ditlev et al., 2018). In 
order to test if CFP-PfTLP-LCR2 could be recruited into LLPS droplets formed by  
YFP-PfTLP-LCR1, YFP-PfTLP- LCR1 and CFP- PfTLP-LCR2 were combined at a concentration of 
14 µM in the presence of 25 % PEG. Fluorescent microscopy revealed formation of droplets 
containing YFP but lacking CFP (Fig. 29, panel B). CFP-PfTLP-LCR2 remained uniformly in 
solution. Interestingly, the droplet size of YFP- PfTLP-LCR1 increased significantly with time 
(Fig. 29, panel C). However, even after prolonged incubation times recruitment of CFP-PfTLP-
LCR2 into the droplets formed by YFP-PfTLP-LCR1 was still undetectable. Taken together, 
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these results provide first evidence that PfTLP-LCR1 can undergo LLPs. However, a role of 
PfTLP-LCR2 in LLPS could not be observed under these conditions. 
Figure 29: PfTLP LCR1 mediates liquid-liquid phase separation.  Microscopy images of phase 
separation experiments. (A) 14 µM YFP-PfTLP-LCR1 or CFP-PfTLP-LCR2 or (B, C) 14 µM YFP-
PfTLP-LCR1 and 14 µM CFP-PfTLP-LCR2 were incubated in the presence of 25 % PEG and 
150 mM KCl (pH 7.4). Reactions were visualized at immediately  (A, B) or after 2 h 
incubation at room temperature (C), fluorescent microscopy, using indicated filters for 
the detection of YFP or CFP,  or by differential interference contrast microscopy (DIC, 
panel A). Panels represent the same reactions, but not the same images. Image exposure 
adjusted for the detection of phase separated droplets. Scale bar represents 10 µm.  
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Chapter 4 
Discussion 
4.1 Bioinformatics analysis of PfTLP 
Phylogenetic tree analysis grouped PfTLP with the TRF2-type TLPs. However, PfTLP has four 
key phenylalanine residues, vital for TBP DNA binding, conserved, whereas typical TRF2 type 
TLPs lack one or more of these phenylalanine residues. Another difference between PfTLP 
and typical TRF2-type TLPs is the presence of two low complexity regions that extend out of 
the core domain structure. These regions are predicted to be intrinsically disordered and 
mediate LLPS.  
A previous study on the evolution of the TRF2-type TLPs postulated that the gene duplication 
event, which led to the emergence of TRF2-type TLPs, happened prior to the development of 
the bilateria, but after the evolutionary split between the bilaterian and nonblilaterian 
animals (Duttke et al., 2014). This is consistent with the observation that typical TRF2-type 
TLPs, lacking the phenylalanine residues required for TBP DNA binding,  are only found in 
metazoans (Dantonel et al., 1999).  It is hypothesized that the emergence of the TRF2-type 
TLPs allowed for an expansion of gene regulatory programs that facilitated the development 
of complex body plans (Dantonel et al., 1999; Duttke et al., 2014). The common ancestor of 
TRF2-type TLPs appears to have emerged in a lineage that branched off from the protists. 
Furthermore, while there are protist TBP/TLPs that lack the evolutionary conserved 
phenylalanine residues, these may have resulted from convergent evolution.   
Distinct TBP and TBP-like genes have been found in a range of eukaryotic organisms, including 
plants and protists, suggesting that different organisms evolved unique TBP/TBP-like proteins 
(Dantonel et al., 1999; Guillebault et al., 2002; Ruan et al., 2004). For example the only TBP 
protein found in the unicellular eukaryotic organism Crypthecodinium cohnii (Guillebault et 
al., 2002), was found to be structurally closely related to eukaryotic TBPs, with the signature 
core domain repeats and the interactions sites for TFIIA and TFIIB conserved. However, this 
TBP lacked the four phenylalanine residues, required for TBP sequence-specific DNA binding, 
73 
 
and also showed only very weak TATA box affinity. Thus, functionally this C. cohnii TBP be 
considered a C. cohnii specific TBP-like protein (Guillebault et al., 2002).  Similarly, the human 
parasite Trypanosoma brucei lacks a gene for a bona fide TBP, but possesses a TBP-like factor, 
called TRF4. Interestingly, P. falciparum TBP, possesses only three of the four evolutionary 
conserved phenylalanine residues required for TBP DNA binding, with one of the intercalating 
phenylalanine residues substituted by isoleucine. Furthermore, while PfTBP appears to bind 
preferentially AT-rich sequences, it lacks TATA box-specific DNA-binding activity (Milton, 
2017).  
Taken together, these observations suggest that P. falciparum may have independently 
evolved two unique TBP-like proteins with unusual properties, as a means to facilitate the 
complex life cycle of the parasite.  This might indicate that, although phylogenetic analysis 
based on amino acid sequence homology places PfTLP in the TRF2-type TLP clade, it might in 
actual fact be a Plasmodium-specific TBP-like protein, not functionally related to TRF2-type 
TLPs identified in metazoans.  
4.2  PfTLP DNA binding  
Characterization of PfTLP DNA binding activity led to the following observations. First, PfTLP 
binds stably to DNA sequences even at elevated temperatures of up to 42 °C and at elevated 
salt concentrations up to 460 mM KCl (Chapter 3.3, Fig. 15).  
Eukaryotic TBP binds to the TATA box promoter element through the minor groove of the 
DNA via an induced fit mechanism (Kim et al., 1993; Nikolov et al., 1992, 1996), slightly 
unwinding the DNA helix to expose and interact with the base pairs (Kim and Burley, 1994). 
The TBP/DNA complex is clamped in place through the actions of four phenylalanine residues. 
Two of these residues intercalate between the first and last base pairs of the TATA box 
element. These phenylalanine residues will interact with the nucleobases through van der 
Waals and π – π interactions to compensate for the loss of base stacking. The intercalation by 
the phenylalanine residues causes kinks in the DNA and the two additional phenylalanine 
residues support the kinks by interacting with the ribose backbone through van der Waals 
interactions. The two kinks compress the DNA towards the major groove, causing a dramatic 
bend in the DNA of roughly 90° (Chapter 1.2.4, Fig. 2, Kim, Nikolov & Burley, 1993; Kim & 
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Burley, 1994). Previous studies have shown that substitutions of intercalating phenylalanine 
residues results in a drastic loss of TBP in vitro DNA-binding activity, suggesting that these 
residues are essential for TBP DNA binding (Kamenova et al., 2014; Klejman et al., 2005; Zhao 
et al., 2003). In PfTLP, conserved phenylalanine residues appear not to be required for DNA 
binding activity, but appear to play an important role in PfTLP/DNA complex stability, with 
F60 playing a much more important role than F283. Furthermore, the F283 residue appears 
to contribute to the preferential binding of PfTLP to A/T-rich sequences (chapter, Fig. 20).   
4.2.1 PfTLP DNA binding conditions  
Previous studies have determined the ideal binding conditions for prototypical TBPs isolated 
from human, S. cerevisiae, and Drosophila cells. These studies have revealed that human TBP 
is completely inactivated by heat treatment at 47 °C for 15 min , however, when complexed 
with DNA TBP is heat stable up to 70 °C (Coleman and Pugh, 1995; Nakajima et al., 1988).  The 
ideal incubation temperature for TBP DNA binding experiments was determined to be 30 °C, 
with TBP DNA binding activity diminished in temperatures above or below 30 °C (Petri et al., 
1995).  In the case of PfTLP no difference in DNA binding activity was seen at incubation 
temperatures from 0 °C to 42 °C, however at 60 °C, PfTLP appears to denature (Fig. 15). 
Although the ideal PfTLP DNA binding conditions were not determined in this work, it can be 
concluded that the standard 30 °C incubation temperature established for TBP DNA binding 
experiments is still suitable for studying PfTLP DNA binding.  
TBP DNA binding involves both hydrophobic as well as electrostatic interactions. TBP binding 
to the minor groove of the DNA involves hydrophobic interactions with the edges of base 
pairs, this process is entropically driven due to the release of water molecules during complex 
formation (Privalov et al., 2007, 2011). In addition there are electrostatic interactions 
between the overall positively charged DNA binding surface and the negatively charged DNA 
backbone. The contribution of electrostatic interactions to TBP DNA binding activity is 
illustrated by the observation that salt concentrations above 60 mM KCl in the binding 
reaction drastically diminishes TBP DNA binding activity (Petri et al., 1995). In contrast, PfTLP 
DNA binding was unaffected by high salt concentrations, and stable binding was still 
detectable at 460 mM KCl. This observation suggests that, compared to TBP, PfTLP DNA 
binding may be mediated through mostly hydrophobic interactions, and to a lesser extent by 
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electrostatic interactions. This interpretation is supported by the presence of hydrophobic 
amino acid residues in the predicted PfTLP DNA binding surface (Chapter, Fig. 6A and 23). Of 
note, DNA binding by TBP from the hyperthermophilic archaeon Pyrococcus woesei at high 
salt concentrations is also primarily mediated through hydrophobic interactions (O’Brien et 
al., 1998).  
4.2.2 The effects of the phenylalanine residues on PfTLP DNA binding 
In PfTLP the core domain architecture of model eukaryotic TBP appears conserved, and is 
enriched in hydrophobic residues (Chapters 1.2.4).  Furthermore, the phenylalanine residues 
predicted to intercalate into the DNA during TBP sequence-specific DNA binding are 
conserved in PfTLP. These observations support the idea that PfTLP binds DNA in a similar 
manner to eukaryotic TBP, through a hydrophobic DNA binding surface and the action of the 
conserved phenylalanine residues, and imply that PfTLP may also have sequence-specific DNA 
binding activity. In this study, the two phenylalanine residues that were predicted to 
intercalate into the DNA during PfTLP sequence specific binding, F60 and F283A, were 
mutated to alanine residues to produce two single PfTLP mutants, F60A and F283A, and a 
double mutant, F60&283A.  
In DNA binding experiments using EMSAs without Mg2+ present during electrophoresis the 
double mutant  F60&283A showed lower DNA binding activity than the two single point 
mutants, suggesting that both F60 and F283 contribute to some extent to overall PfTLP DNA 
binding activity. In ITA experiments, the DNA-binding activity of PfTLP carrying the F60A 
substitution was strongly diminished, whereas the F283A mutation had only little effect. 
Furthermore, in EMSA experiments with Mg2+ present during electrophoresis DNA binding 
activity of the F60A mutant was undetectable, suggesting that  F60 is critically important for 
PfTLP/DNA complex stability (Chapter 3.3.1). These results contrast earlier observations made 
for human and yeast TBP, where both phenylalanine residues were found to be equally 
essential for DNA binding (Kamenova et al., 2014; Klejman et al., 2005; Zhao et al., 2003). 
Interestingly, a comparison of the crystal structures of AtTBP2 and HsTBP bound to the Ad2ML 
TATA box sequence demonstrated differences in the extent of phenylalanine residue 
intercalation, which in turn affected the trajectory of the DNA exiting the respective 
DNA/protein complexes (Nikolov et al., 1996).  This observation raises two important points. 
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First, the two phenylalanine residues in a single TBP molecule may not intercalate to the same 
extent. Second, the degree of base intercalation by conserved phenylalanine residues differs 
between TBPs from different species, resulting in different degrees of overall DNA bending 
and, consequently, in a different trajectory of the DNA emanating from the TBP/TATA 
complex. It seems therefore possible that the extent to which F60 and F283 intercalate into 
DNA upon DNA binding by PfTLP differs considerably or that only the F60 residue intercalates 
into the DNA at all. This may suggest that the degree of DNA bending and thus the overall 
topology of the PfTLP/DNA complex may be dramatically different to that seen in prototypical 
TBP/DNA complexes.  
4.2.3 DNA binding modes and sequence specificity  
The results of this study suggest two modes of PfTLP DNA binding. First, a mode that is 
independent of the conserved phenylalanine residues, based on the observation that the 
double mutant, F60&283A, retained DNA binding activity. Second, a mode of DNA binding 
that is depended the conserved phenylalanine residues, based on the observation that  
F-to-A substitutions resulted in reduced DNA binding activity. For DNA-binding proteins three 
basic modes of DNA binding may be considered – specific DNA binding, nonspecific DNA 
binding and unspecific DNA binding. Specific DNA binding refers to the recognition of and 
binding to a specific DNA sequence element, with significantly higher affinity compared to 
unrelated DNA sequences. Nonspecific DNA binding refers to binding of a sequence-specific 
DNA-binding protein to a sequence unrelated to it is recognition sequence. Lastly, unspecific 
DNA binding occurs when a protein shows no sequence preference (Murphy & Churchill, 
2000). Eukaryotic TBP possesses both sequence-specific and nonspecific DNA binding activity, 
both of which are mediated through the hydrophobic DNA binding interface of TBP (Coleman 
& Pugh, 1995). Mutational analysis suggest eukaryotic TBP sequence specific DNA binding 
depends on the four evolutionary conserved phenylalanine residues (Zhao et al., 2003; 
Klejman et al., 2005; Kamenova, Warfield & Hahn, 2014). In this study, binding to an A/T-rich 
GBP-130 DNA probe by the PfTLP F283A mutant was shown to more sensitive to challenge by 
an excess poly(d-G-dC) competitor DNA than wildtype PfTLP. This result suggests binding 
selectivity of PfTLP for A/T-rich DNA mediated by (a) conserved phenylalanine residue(s). We 
have so far not been able to demonstrate TATA sequence-specific DNA binding by PfTLP or 
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PfTBP (Jasmin Knopp and Thomas Oelgeschläger, unpublished) and the question whether or 
not PfTLP has preference for a specific A/T sequence remains to be answered. 
4.2.4 Outlook  
The sequence specificity of PfTLP may be further investigated using modified EMSA and ITA 
competition experiments, or by using a systematic evolution of ligands by exponential 
enrichment (SELEX) approach (Milton, 2017). If sequence-specificity can be established it 
would also be interesting to compare wildtype PfTLP with the mutants carrying F-to-A 
substitutions in order to further elucidate the role of phenylalanine residues in PfTLP 
sequence-specific DNA binding. Recent work on PfTBP in the laboratory established A/T 
preference for PfTBP DNA binding but a specific A/T sequence motif could not be determined 
using a SELEX approach (Milton, 2017). Further work is required to determine whether PfTBP 
and PfTLP represent two unique Plasmodium-specific TBP/TBP-like proteins with distinct 
DNA-binding properties.  
While results of this work suggests a role of conserved phenylalanine residues in PfTLP DNA 
binding, it remains unclear whether PfTLP DNA binding also results in DNA bending. Provided, 
sequence specificity can be established for PfTLP, the degree of DNA bending by PfTLP and 
the effect of F-to-A mutations could be investigated using circular permutation assays 
(Bernués et al., 1996; Horikoshi et al., 1992; Starr et al., 1995).  
Finally, the important question of the effect of PfTFIIA and PfTFIIB interactions with PfTLP 
need to be further investigated (Milton, 2017; Talvik, 2016). Purified recombinant PfTFIIA and 
PfTFIIB have been produced in the laboratory (Bing, 2014; Milton, 2017; Talvik, 2016), that 
could be used to investigate whether PfTFIIA and/or PfTFIIB interactions affect PfTLP DNA-
binding activity and, potentially, compensate for the effect of F-to-A substitutions in PfTLP.   
4.3  Low Complexity Regions  
4.3.1 PfTLP LCRs amino acid enrichment is consistent with literature  
Recent studies have identified an increasing number of proteins, involved in essentially all key 
cellular processes, that are able to drive LLPS, of which a  large proportion have regions of low 
complexity (LCR), which in many instances gives rise to intrinsic disorder (Ditlev et al., 2018). 
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The relationship between low complexity and the propensity to drive LLPS has been discussed 
for many proteins (reviewed in Martin and Mittag, 2018). Briefly, due to the multitude of LCR 
functions these regions come in a variety of “flavours” or archetypes. For example, polar LCRs 
that mediate LLPS have been shown to be particularly enriched in polar amino acids like 
serine, glutamine, and, asparagine. These regions tend to be further enriched in glycine 
residues, which provide a large degree of conformational flexibility. Polar LCRs that mediate 
LLPS tend to have upper critical solution temperatures (UCST), and phase separate at lower 
temperatures, through a process mediated by multivalent interactions. The phase separating 
activity of many polar LCRs appears to be mediated by the following amino acid sequence 
features. Firstly, these regions tend to contain randomly dispersed aromatic residues, which 
are able to engage in π – π and π – cation interactions (Martin and Mittag, 2018). Secondly, 
these regions are often punctuated with charged amino acids, which add to random 
electrostatic interactions (Martin and Mittag, 2018). 
 The analysis of the amino acid enrichment and patterning of the LCR1 and LCR2 regions of 
PfTLP reflected some of these observations. Firstly, both PfTLP LCR1 and LCR2 regions are 
particularly enriched in polar amino acids, such as asparagine and serine.  Particular 
enrichment in asparagine may be due to the genome wide A/T bias (Aravind et al., 2003; Pizzi 
and Frontali, 2001).  Secondly, PfTLP LCR1 and LCR2 regions are also punctuated with aromatic 
and charged amino acid residues. One key difference between the reported properties of 
polar LCRs and PfTLP LCR1 and LCR2 is the lack of glycine.  It seems possible that the 
underrepresentation of glycine in P. falciparum is due to its G/C codon. Taken together these 
observations supported a possible involvement of PfTLP LCR1 and LCR2 in LLPS, and suggests 
that these regions, due to their polar nature might be classified as UCST LCRs.  
4.3.2 LCR conservation in Plasmodium genus  
Multiple sequence alignments and DisMeta analysis demonstrated the existence of LCR1 and 
LCR2 regions, of similar length as in PfTLP, between the core domain structures of β-strands 
S3/S4 and S3’/S4’  in all  Plasmodium TLP orthologues  (Fig. 6B). This analysis also revealed a 
high level of identity between the TLP amino acid sequences from P. falciparum, P. 
reichenowi, and P. gaboni LCRs. This was not an unexpected result since these species are 
part of the Plasmodium subgenus of Laverania, which are evolutionary very closely related 
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and therefore share over 90% amino acid sequence identity. The subgenus Laverania 
specifically infects primate hosts, such as humans, chimpanzees, and gorillas in sub-Saharan 
Africa. In contrast, TLP orthologues outside of the subgenus Laverania  showed very little 
sequence conservation in LCR1 regions, and do  not appear to be enriched in the same amino 
acid residues either. This is not surprising as LCR/IDRs generally show high rates of evolution 
(Turoverov et al., 2019). Importantly, Plasmodium species outside Laverania and therefore 
more distantly related to P. falciparum have different genome nucleotide biases, which 
impact the enrichment of specific amino acid residues within LCRs. This might indicate that 
PfTLP LCR1 regions have evolved different functions within the various species. However, 
LCRs that mediate LLPS have been shown to be able to accommodate high levels of sequence 
divergence without loss of LLPS function (Turoverov et al., 2019).  In contrast to LCR1,   LCR2 
sequences were found to have a significant degree of sequence similarity between the various 
Plasmodium TLP orthologues. This might indicate a specific evolutionary conserved function 
of TLP LCR2, perhaps outside of LLPS, within the various Plasmodium species. 
4.4  Liquid-Liquid Phase Separation Assays  
4.4.1 Observation of LLPS 
This study provides first evidence for the possible role of PfTLP LCR1 region in driving LLPS, 
and hence forms the basis for future research into this important new aspect of gene 
regulation.  The results from phase separation assays demonstrated that PfTLP-LCR1 is 
capable if driving LLPS in vitro. PfTLP LCR1 might be considered to have an upper critical 
solution temperature (UCST), given that it phase separates at room temperature.  
4.4.2 Relevance 
A number of recent studies have highlighted the importance of LLPS in the regulation of RNA 
polymerase II transcription. However, these studies have focused on RNA polymerase II, the 
mediator complex coactivator and the DNA binding transcription factor activator domains 
(Boija et al., 2018; Chong et al., 2018; Guo et al., 2019; Gurumurthy et al., 2019; Larson et al., 
2011; Sabari et al., 2018; Shrinivas et al., 2019). Studies at super-enhancers suggest that LLPS 
involving the mediator complex and activation domains serve to concentrate the transcription 
machinery at target genes during gene activation (Boija et al., 2018; Chong et al., 2018; 
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Gurumurthy et al., 2019; Sabari et al., 2018; Shrinivas et al., 2019). It was further shown that 
the phosphorylation status of the C-terminal domain of RNA polymerase II (RNAPII) 
determines the association of RNAPII with either the mediator complex at super-enhancers 
(hyperphosphorylated) or membraneless splicing organelles (hypophosphorylated) (Cho et 
al., 2018; Guo et al, 2019.). Up to now, there is no literature on the possible involvement of 
the general transcription machinery in LLPS. This study provides first evidence for the possible 
involvement of a general transcription factor in LLPS.  
4.4.3 Limitations and Outlook 
More work needs to be done to further characterize the LLPS properties of PfTLP and to 
investigate the relevance of the in vitro observations.  
Firstly, the conditions under which PfTLP LCR1 drives LLPS need to be determined. This can 
be done through systematic analysis of PfTLP LCR1 LLPS at different concentrations of protein, 
salt, and crowding agents (PEG/Dextran) as well as under different temperatures and 
incubation times. Secondly, the precise liquid-like properties of the observed spherical 
protein assemblies needs to be examined by observing fusion events between droplets, and 
by fluorescence recovery after photobleaching (FRAP) experiments, which demonstrate rapid 
diffusion of PfTLP LCR1 between droplets and the surrounding solution (Alberti et al., 2019). 
Thirdly, the role of the full length wild-type PfTLP in LLPS has to be determined, by testing its 
ability to drive LLPS, or to be recruited into membraneless organelles.  
Fourth, the amino acid determinants mediating the LLPS activity of PfTLP LCR1 needs to be 
determined.  For example, repeating units of phenylalanine and arginine with glycine (FG/RG) 
were shown to be critical for the phase separating behaviour of the DDX4 protein (Nott et al., 
2015). Furthermore, alternating the positions of charged residues within the DDX4 protein 
also leads to a change in phase separating behaviour (Nott et al., 2015). Additionally, studies 
of the fused in sarcoma (FUS) RNA binding protein found that mutating repeating units of 
tyrosine to serine resulted in a change in hydrogel formation and cellular localization (Kato et 
al., 2012). Together, this indicates that certain amino acid patterns within LCRs have a higher 
propensity to drive LLPS than others. Similarly, the role of the repeating asparagine and serine 
residues in PfTLP-LCR1 LLPS can be investigated by generating deletion and substitution 
mutant proteins and testing their LLPS properties.  
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Additionally, the phase separation assays were so far conducted in a one (LCR1) or two 
component (LCR1 + LCR2) system. However, cellular membraneless organelles are complex 
assemblies that contain multiple protein and nucleic acid partners. It would therefore be 
interesting to test whether PfTLP can form LLPS assemblies with other P. falciparum basal 
transcription factors. The majority of human and P. falciparum (putative) basal transcription 
factors, including TFIIA, TFIIB, TFIIE, TFIIF and TFIIH appear to contain LCRs with the potential 
to phase separate (Leonidas Karamanof and Thomas Oelgeschläger, unpublished). It would 
be interesting to see how these transcription factors interact, and if they can form higher-
order phase separated assemblies.  If such higher order assemblies are identified, it would be 
important to see which proteins act as scaffold proteins, and recruit additional proteins into 
phase separated droplets. The ability of membraneless organelles to recruit and concentrate 
molecules and proteins involved in similar cellular functions is well documented and can be 
experimentally corroborated in vitro and in vivo through recruitment assays. (Alberti et al., 
2019; Dao et al., 2018; Sheu-Gruttadauria and Macrae, 2018; Woodruff et al., 2017).  It would 
be interesting to test if the P. falciparum and human proteins have different LLPS properties, 
as this might open new avenues for anti-malarial drug development.  
Finally, the role of PfTLP LCR2 in LLPS could not be determined in this study, and this is likely 
due to the limited set of conditions that were tested. A wider range of experimental 
conditions needs to be employed to determine a possible involvement of LCR2 in PfTLP LLPS.  
Conclusion 
This study provided the initial characterization of a Plasmodium-specific general transcription 
factor, PfTLP. It was shown that PfTLP possesses DNA binding activity, which might be 
mediated through hydrophobic interactions. DNA binding was not dependent on the action 
of the two evolutionary conserved phenylalanine residues, F60 and F283, predicted to be 
important for TBP DNA binding. However, these two phenylalanine residues, especially F60, 
are important for PfTLP/DNA complex stability. Additionally, it was shown that PfTLP 
possesses two low complexity regions that extend out from the core domain structure, which 
are conserved in the Plasmodium genus. These LCRs have the hallmarks of polar LCRs that 
drive LLPS, and it was shown that PfTLP LCR1 is able to phase separate in vitro. Taken together, 
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this study provides first insight into the possible functions of PfTLP, and contributes to a better 
understanding of transcription initiation and gene expression in this globally important 
parasite 
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Supplementary Material  
 
 
Supplementary Figure 1: Plasmid map of pET11d-6His-CFP-LCR2  
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Supplementary Figure 2: Plasmid map of pET11d-6His-GFP-LCR2  
85 
 
 
 
Supplementary Figure 3: Plasmid map of pET11d-6His-YFP-LCR1 
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Supplementary Table 1: Primers used for the generation of fluorescently labeled LCRs.  
Primer  Sequence (5’-3’)  
GFP-LCR1-FWD tctcggcatggacgagctgtacaagCCGGTTACCCTGAGTACGG 
GFP-LCR1-REV gcaccgtactcagggtaaccggCTTGTACAGCTCGTCCATGC 
GFP-LCR2-FWD cggcatggacgagctgtacaagATTGCCCTGATGAACGATGAAAAC 
GFP-LCR2-REV tgttttcatcgttcatcagggcaatCTTGTACAGCTCGTCCATGC 
LCR1-REV tagcagccggatccttatcaGATCAGTTTTTTGTTGATGATATGTTC 
LCR2-REV tagcagccggatccttatcaACTGGCAGAGACGATATCAACTT 
eGFP-FWD gcggcagccatATGGTGAGCAAGGGCGAGG 
pEarlyGate FWD gcggcagccatatgGTGAGCAAGGGCGAGGAG 
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CLUSTAL O(1.2.4) multiple sequence alignment of Plasmodium TLPs (page 1 of 2) 
 
 
Pv         ---------------------------MSVHNISMNATLCSSLNLDSLYRHFANCIYNPR 33 
Pg         --MYPPCKKKKLNNNEVTNIFLKNENKMSVHNISMNAVLCSSLNLDNIYKYFSNCIYNPR 58 
PfTLP      --MYPPCKKKKLNNNEVTNIFLKNENNMSVHNISMNAVLCSSLNLDNIYKYFSNCIYNPR 58 
Pr         --MYPPCKKKKLNNNEVTNIFLKNENNMSVHNISMNAVLCSSLNLDNIYKYFSNCIYNPR 58 
Po         --MSQPVKKSKLSYTESKNIFVNNENSMSVHNISMNAVLCSTLNLDSIYRYFANCIYNPR 58 
Pm         MKMSQPLKRSKLNNNESQNIFVKNENSMSVHNISMNAILCSSLNLDSIYKYFSNCIYNPR 60 
Prel       --MCNPSKRTKLNNNEINNIFIKNEHNMSVHNISMNAILCSSLNLDSIYKYFSNCIYNPR 58 
Pca        --MEHALKKIKLNNNESKNIYINNANNMSVHNISMNAILCSSLNLDSIYKYFSNCVYNPR 58 
Py         --MEHVSKKIKLDNNESKNIYINNSNNMSVHNISMNAILCTSLNLDNIYKHFSNCVYNPR 58 
                                      ********** **::****.:*::*:**:**** 
 
Pv         EFKCMRIDVPVSTRSISKYVRFVQQKGGRQTGETQTGETQTGETQ-TGETQT--GETQTG 90 
Pg         EFKCMRIDVPVSLNTVHKYIKYLNNKKERQNDDISKMKNEQENEAIHSNNYIKEENITTE 118 
PfTLP      EFKCMRIDVPVTLSTVQKYIKYLNNKKEKQNDDICKMKNEQVNQTKHSNNNIKEEIKTNG 118 
Pr         EFKCMRIDVPVTLSTVQKYIKYLNNKKEKQNDDICKMKNEQVNQTKHSNNNIKEEIKTTG 118 
Po         EFKCMRIDVPVSLKTVNKYVNYLREKRERGKRERVMEEMEREELEKCSREQLKKEEKDEA 118 
Pm         EFKCMRIDVPVSLKTVHKYVNYVKNKRKKEQQGIEVEINKQEDSSYKGVDNNCKEVSNNC 120 
Prel       EFKCMRIDVPVSLRTVNKYVNYINNKKERDDKYKLKDEK-YKQIKEKNEKKF-DDIKNEK 116 
Pca        EFKCMRIDVPVSLSTVNKYVNHIKNKEKLKTE--------------KNQNEVCMDVENDS 104 
Py         EFKCMRVDVPVSLNTVNKYIDYIKNKEKIQTEQTEQTEQ-TNLVTKNNKNEICMPVENNS 117 
           ******:****:  :: **: .:.:*                     .             
 
Pv         EKPTGEEQ-----TGEKQTGEKPTGEEQKG-SEGVIPPSDGT----SVVTP-SAPPPDVA 139 
Pg         SNKLNDNK----LSDS--NN---------SSSGKILTDNKSD-ENSINISKNKSNIDD-- 160 
PfTLP      SNKLSDNK----LLDS-SNN---------SSSNKILTNNKSH-ENLINISKNNSYLDD-- 161 
Pr         SNKLSNNK----LLDS-SNN---------SSSDKILTNNKSH-ENLINISKNNSYLDD-- 161 
Po         KEKKEDEIDVAEIVTEQCNNE--VPEEGKVSPPEKVNKDTG-IH-ESD-IPNNEIPAAE- 172 
Pm         DMPSGGNTS-FPIDDGKCSMP--DS--VHVSS-----------TANKASS---------- 154 
Prel       VKK-DDDI-----ENEKEESE--EK--KEIVSEKIIDNNKNYIKDNKNISNDNYIPFDET 166 
Pca        NKPLPTQT-----NTT---------------------------NFNINIEPNNYYPPEIK 132 
Py         NKDTSTQL-----FNKKSNNN--DN--IEHNNDNIEHNNDNIEHNNDNIEHNNYGSSGIK 168 
                 :                                                      
 
Pv         TT--CQVVE--------AT-------TSQGGGNPPEEHTEANEKVIINVSIFANGKIICT 182 
Pg         NNSEIK-----------KNTDIIYDMET--MDPFNESEHTMNKKLIINVSIFSNGKIICT 207 
PfTLP      NVNKNNFFI--NDNNSDNKKIDTSDIKN--MDPFIESEHIINKKLIINVSIFSNGKIICT 217 
Pr         NVNKNNFVI--NDNNSDNKKIDTYDIQT--MDPFIESEHIINKKLIINVSIFSNGKIICT 217 
Po         -----------SATLSDDFFLKGGYEKLVSNDFSEHYNDNVGEKLVINVSIFSNGKIICT 221 
Pm         ---SNAEVSARNDHISGESNYINSVI----EK-INENYKDVTEKLVINVSIFSNGKIICT 206 
Prel       EN--INSII--NEDISDTKNDKSNDIVEYS----IENNNVVNKKLIINVSIFSNGKIICT 218 
Pca        YIDGIPM---------------------FEDKNDEDD--YTSEKLVINVSIFSNGKIICT 169 
Py         HNDEIQNFEEKNDEV-QNFEEKNDEIQKFEEKNDEDDHYTTSEKLVINVSIFSNGKIICT 227 
                                              .      :*::******:******* 
 
Pv         GNNSIEACKIAMKKIERKLKQLNFKNISIKNVTITNILAVYNVGFSIVLPLFAQYYKSVD 242 
Pg         GNNSIEACKVAMKKIEKKLKQLNFKNIKLKKITITNILAVYNVGFSIVLPLFAQYYKSVD 267 
PfTLP      GNNSIEACKIAMKKIEKKLKQLNFKNIKLKKITITNILAVYNVGFSIVLPLFAQYYKSVD 277 
Pr         GNNSIEACKIAMKKIEKKLKQLNFKNIKLKKITITNILAVYNVGFSIVLPLFAQYYKSVD 277 
Po         GNNSIEACKIAMKKVEKKLKFLNFKNIKLKKITITNILAVYNVGFSIVLPLFAQFYKNVD 281 
Pm         GNNSIEACKIAMKKVEKKLKQLNFKNIKLKKITIANILAVYNVGFSIVLPLFAQYYKSVD 266 
Prel       GNNSIEACKIAMKKVEKKLKQLNFKNIKLKKITITNILAVYNIGFSIVLPLFAQYYKSVD 278 
Pca        GNNSIEACKIAMKKVEKKLKQLNFKNIKLKKIAITNILAVYNVGFSIVLPLFAQYYKSVD 229 
Py         GNNSIEACKIAMKKVEKKLKQLNFKNIKLKKIAITNILAVYNVGFSIVLPLFAQYYKSVD 287 
           *********:****:*:*** ******.:*:::*:*******:***********:**.** 
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CLUSTAL O(1.2.4) multiple sequence alignment of Plasmodium TLPs (page 2 of 2) 
 
 
Pv         YDPNVFPACKVKIALTSDSERDTSEASEQAEGNFAWSTPRSTAERSRSKVDVVSASIFST 302 
Pg         YDPNVFPACKVKIALMNDDNKS-NDNNELNDNNYAWCNAKNTIDKDKSKVDIVSASIFST 326 
PfTLP      YDPNVFPACKVKIALMNDENKS-NDNK-ENDNNFAWCNAKNTIDKDKSKVDIVSASIFST 335 
Pr         YDPNVFPACKVKIALMNDENKS-NDNK-EHDNNFAWCNAKNTIDKDKSKVDIVSASIFST 335 
Po         YDPNVFPACKVKIALTNEDEKNASERREQNDCTYAWCSAKSTADKEKSKVDIVSASIFST 341 
Pm         YDPNVFPACKVKIALTNEDKKNLSERKEQNESTYAWCNANNNIDSGKSKVDIVSASIFST 326 
Prel       YDPNVFPACKVKIALINENEKNCDEKNEENNSQYAWWNIKKTAEKEKNKVDVISASIFST 338 
Pca        YDPNVFPACKVKIALTNDDNNTSSELNEQNDSSYAWCTSRPTIETSKSKADVVSASIFST 289 
Py         YDPNVFPACKVKIALSNDDNNNSSEHNEQNDSAYAWCTNKPIFESNKNKTDVVSASIFST 347 
           *************** .:.:.  .:     :  :** . .   :  :.*.*::******* 
 
Pv         GNITLTGGKSYQNLQRCIDILYPYLIKSKSQH 334 
Pg         GNITLTGGKSYENLQKCINILLPYLIKSKSQH 358 
PfTLP      GNITLTGGKSYENLQKCINILLPYLIKSKSQH 367 
Pr         GNITLTGGKSYENLQKCINILLPYLIKSKSQH 367 
Po         GNITLTGGKSYENLQRCIDILLPYLIKSKSQH 373 
Pm         GNITLTGGKSYENLQRCIDILLPYLLKSKSQH 358 
Prel       GNITLTGGKSYENLQKCIDILLPYLIKSKSQH 370 
Pca        GNITLTGGKSYDNLKKCIDILLPYLIKSRSQH 321 
Py         GNITLTGGKSYDNLKKCIDILLPYLIKSKSQH 379 
           ***********:**::**:** ***:**:*** 
 
Pv = Plasmodium vivax  
Pg = Plasmodium gondii 
Pr = plasmodium reichenowiium 
Po = plasmodium ovale 
Pm = plasmodium malariae 
Prel = plasmodium relictum 
Pca = plasmodium chabaudi adami 
Py = plasmodium yoelii 
 
Supplementary Figure 4 : Multiple sequence alignment of Plasmodium TLP orthologues.  
Light grey letters indicated amino acid residues in LCR1 and LCR2 of PfTLP. Conserved 
phenylalanine residues, corresponding to those required for TBP sequence-specific DNA 
binding are shown in red. 
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Supplementary Table 2: DNA probes used in this study. Uppercase letters refer to PCR primer 
sequences, italics refer to GAL4 binding sites.  
Probe Length Experiment Sequence Biotinylation 
GBP-
130  
422 bp  ITA  5’AATTGGGCCCGACGTCGCAtgctcctctagagcttgcatgcctgc
aggtcggagactgtcctccgagcggagtactgtcctccgagcggagt
actgtcctccgagcggagtactgtcctccgagcggagtactgtcctc
cgagcggagactctagaattctttgaagtacactcaaaataagttat
ataccatatgtttttaacatatattatatatatatatatatatataa
tataatataatattataattattttttaatattattaaattgaacat
aattattttatatcttactattatttttagaaaatttattatatata
catgcaatcataaataatgttttccctgaaccttttttcaatgaaat
aagttaacacaccattcctttGGATCCGGAGAGCTCCCAACGCGTT3
’ 
 
5’  
GBP-
130 
288 bp  EMSA  5’CGAGCGGAGACTCTAGaattctttgaagtacactcaaaataagtt
atataccatatgtttttaacatatattatatatatatatatatatat
aatataatataatattataattattttttaatattattaaattgaac
ataattattttatatcttactattatttttagaaaatttattatata
tacatgcaatcataaataatgttttccctgaaccttttttcaatgaa
ataagttaacacaccattccttttGGATCCGGAGAGCTCCCAACGCG
T3’  
 
3’ and 5’  
GBP-
130  
30 bp  EMSA  (+) 5’- GAAAATTTATTATATATACATGCAATCATA 
(-) 5’- TATGATTGCATGTATATATAATAAATTTTC 
3’ and 5’  
Ad2M
L  
40 bp  EMSA  (+)5’- GTTCCTGAAGGGGGGCTATAAAAGGGGGTGGGGGCGCGTT 
(-)5’- AACGCGCCCCCACCCCCTTTTATAGCCCCCCTTCAGGAAC 
3’ and 5’  
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Supplementary Figure 5: Protein Sequence of PfTLP, extracted from PlasmoDB accession 
number PF 3D7_1428800.1 
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